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Vitamin A (retinol, 1) is stored in the liver as retinyl palmitate and is essential for th.e 
growth and development of higher life forms and functions in many different ways within 
an organism.68 In mammals, vitamin A is essential for vision [converted to retinal (2)] 
reproduction and the regulation of differentiation and proliferation of a very wide range of 
epithelial tissues. 64 Retinoic acid (3) can substitute for retinol in vitamin A deficient 
animals in growth promotion and cell differentiation.l3 
Retinol (1) all-trans-Retinoic Acid (3) 
Retinal (2) 13-cis-Retinoic Acid (4) 
1 
2 
The term "retinoids" is applied to naturally occurring vitamin A derivatives, such as 
retinol, retinal, and retinoic acid, as well as to synthetic compounds having structural 
similarities regardless of whether they possess biological activity_l9,67 Since the late 
1960's, a number of structurally-modified retinoids (synthetic retinoic acid derivatives) 
have been made with the focus to improve on the ratio of toxic effects (e.g. 
hypervitaminosis A) to the therapeutic activity compared to retinoic acid. 53 Retinoic acid 
(3) consists of three main sections: a lipophilic part at one end connected via a 




\.....__ _ ......, ,----~ y 
spacer 
all-trans-Retinoic Acid (3) 
hydrophilic 
part 
Different synthetic retinoids have been prepared by making alterations in one or more 
parts of the basic retinoic acid skeleton. For example, the hydrophilic C02R group has 
been replaced by a phosphoric ester group as in 5 and sulfonic ester group as in 6.40 
3 
The oxygen-containing metabolites from 3, namely 7-9, are a group of compounds in 
which the cyclohexenyl ring (lipophilic part) has been altered.J8,58,59 Keto acid 9 has 
been shown to be teratogenic.77 
OH 
~ ~ ~ C02C2H5 
Etretinate (10) 
Motretinid (11) 
Aromatization of the cyclohexenyl ring leads to compounds like Etretinate (10) and 
Motretinid (11).48 A ~umber of arotinoids (retinoids with an aryl ring as in 13 and 14) 
4 
have been synthesized12 and have exhibited anticancer activity in several assays but they are 
toxic.45 
Structure 12 illustrates the closeness of these arotinoids to retinoic acid (3). It shows 
how the polyene side of the retinoic acid is condensed into an aromatic ring structure, thus 
making fixed conformations at these bonds and more planar structures. 
Another class of synthetic retinoids are the heteroarotinoidsl8,41,70,76 (retinoids 
consisting of an aryl ring and the heteroatom incorporated in one of the rings as shown 
below in 15) which have also shown anticancer activity with reduced toxicity in several 
assays. This area is in a time of rigorous development. Several members of 15 have 
exhibited reduced toxicity compared to retinoic acid (3).18,70 
X = 0, S, N-CH3 
R = H, CH3, CzH5 
n = 1, 2 
5 
Degradative Biopathways and Metabolism 
Many oxidative pathways for retinoic acid (3) have been suggested from in vitro and in 
vivo studies.24 The major oxidation sites are: (1) the oxidation of the cyclohexenyl ring at 
C(4), (2) the oxidation of one of the methyl groups on the ring and on the side chain, and 
(3) shortening of the side chain as shown below (Figure 1 ). 
~ ~ ~ 02H 
OH 7 










Figure 1. Some Oxidative pathways of all trans-retinoic acid (3): (a) Reference 25; 
(b) Reference 49; (c) Reference 33; (d) Reference 31; (e) Reference 56; 
(t) Reference 32 
Among synthetic retinoids, Etretinate (10) is the most widely studied. Many 
oxidative metabolites have been isolated and characterized from the bile of rats and from 




H3CO H3 "" 24 20 
H3C ~ ~ ~ C02Et 
/ H3CO 10 
"" H3C 0 I 
HO ~ ~ C02H 
HO 
23 
H3C 0 2H 
22 
Figure 2. Etretinate (10) and Its Metabolites 19-21 Isolated From the Bile of the 
Rat 33 and 22-24 Isolated From Human Urine23 
Mode of Action 
6 
The important functions of vitamin A (1) are exerted in the control of normal 
differentiation of epithelial tissues, in bone remodeling to maintain growth, and in 
reproduction.21,50,78,79 Although the biological and biochemical responses to retinoids 
have been studied intensively in a variety of different cell systems, 36, 64,68 the mechanism 
of action is still not fully understood. It is presently clear that retinoids play an important 
role in the control of cell differentiation and in the inhibition of carcinogenesis.19, 68 
7 
It is possible that retinoids may exhibit their responses via more than one independent 
mechanism. There is enough evidence to support the idea that retinoic acid (3) influences 
genomic expression by activating or repressing specific genes. 26 Retinoids are believed to 
affect the expression of these genes at a transcriptional or post-transcriptionallevei.23 
Chytil and OnglO,ll have proposed that the cellular retinoic acid binding proteins and 
cellular retinol binding proteins (CRABP and CRBP, respectively) may be involved in the 
mechanism of action which is reminiscent of that for steroid hormones which act via 
specific receptors that bind to specific sites in the chromatin thereby altering gene 
expression. There are conflicting results regarding an exact mechanism of action and the 
involvement of specific cellular binding proteins. Some studies show that cells which lack 
CRABP do not respond to retinoids 74 whereas other studies show that cells devoid of any 
CRABP respond to retinoids.22,43 Recently, severallaboratories28,54,65 have identified 
nuclear retinoic acid receptors (RAR's), which belong to a family of receptors that include 
the receptors for steroids hormones, thyroid hormones and vitamin D3. It was shown that 
these receptors have a high affinity for retinoic acid (3). These receptors have a molecular 
weight of approximately 50,000 and are largely associated with nucleus. 51 
Retinoic acid receptors appear to act as ligand responsive transcriptional factors and 
likely mediate the action of the retinoids on proliferation and differentiation. 37 Three 
human retinoic acid receptors have been cloned, namely RARa.54 (steroid hormone), 
RAR~ (found in human hepatocellular carcinoma)5 and RARy.42 Recently, another 
retinoic acid receptor (RXRa.) has been cloned46 which is substantially different from 
primary sequence from the previously described RAR's. Thus, possibly CRABP 
transports retinoic acid (3) to the nucleus and 3 is then transferred to the nuclear retinoic 
acid receptor (RAR'S). This pathway represents the retinoic acid-dependent, transacting 
enhancer factor that interacts with a specific sequence in the DNA (see outline below) 
thereby inducing changes in the rate of transcription of specific genes. 
8 
Cell Membrane Nucleus 
Retinoic acid Altered 
........ gene expression 
DNA 
Pharmacology and Toxicity 
It is known that retinoids influence cellular differentiation by modifying gene 
expression. 66 Depending upon the concentration present in the target tissue, retinoids 
either induce or adversely affect the normal biochemical expression of differentiation and 
morphogenesis.71 Clinically the most important retinoids are, to date, 13-cis-retinoic acid 
(4) (Isotretinoin, Accutane, Roaccutan), which has high clinical effectiveness in severe, 
treatment-resistant modulystic acne,75 and Etretinate (10, Tigason, Tegison) or Acritretin ~ 
(Neotigeson, Soriatane) which give significant clinical improvement in severe forms of 
psoriasis, particularly generalized pustular psoriasis.29 Side effects from the oral treatment 
of 13-cis-retinoic acid (4) include abdominal pain, cheilitis, conjunctivitis, xerosis and 
others.44 Etretinate (10) gives some of the same symptoms as natural retinoids but also 
poses two additional problems: (1) there are increasing reports of abnormalities in liver 
function and (2) marked teratogenic properties have been observed, apparently due to the 
long half-life of this drug after chronic therapy.44 
It is difficult to test for the effectiveness or the adverse effect of retinoids since the 
dermatological diseases in which retinoids have shown major effectiveness do not occur in 
animals. The mouse papilloma system is the useful model, although the skin disorders are 
not perfectly comparable, but there are a number of features and morphological analogies to 
skin diseases in human. 
A ~etinoid is considered active when the average diameter of the papillomas per group 
is reduced by 50%.4 This is done by measuring papillomas directly. In addition to the 
-effectiveness, a test is performed to determine the dose levels which produce a defined 
9 
degree of retinoid side effects (hypervitaminosis A). Since various retinoids are 
pharmacologically active at different doses and cause side effects at different doses, it is 
necessary to have a parameter that allows comparision of a large number of retinoids. This 
parameter is called as therapeutic index (T. 1.) and is defined as 
Minimal toxic dose causing hypervitaminosis A T.I. = _ ___;::.;==::;:;.E..::=D=:_:.:::=il=-1===~. ~===~ 
so pap oma regression 
The higher the T.I. value, the better the range between these two values and thus the more 
potent the retinoids (Table I). Table II shows the structures of selected natural and 
synthetic retinoids (arotinoids and heteroarotinoids) and their activity in the ornithine 
decarboxylase (ODC) assay. It gives the IDso values (amount of retinoid required to 
inhibit by 50% the induction of ODC in mouse dorsal epidermis treated with a tumor 
promoter TP A). The ED so is defined in Table III. All trans-retinoic acid (3) and 13-cis-
retinoic acid (4) are used as controls. Modification of the ring to give pentamethyl 
sustituted cyclohexyl ring derivatives showed a good activity (26 Table II). In the benzoic 
acid series (13 and 14, Table II), both acids demonstrated good activities,45 but the 
corresponding esters were found to be less active. When the phenyl ring of compound 14 
was replaced by a furan ring (27, Table II), ether 27 was found to be completely inactive, 
probably due to instability of the ester in the epidermus.16 The heterocyclic derivatives of 
13 (28 and 29) have a heteroatom at the C(5) position where oxidative metabolism 
normally occurs.57 Benzothiopyran derivative 29 was found to be more active than 
benzopyran derivative 28.18,76 The percentage of inhibition as compared to control is 
calculated as follows: 
(ODC with acetone + TP A) - (ODC with retinoid) x 100 
(ODC with acetone + TP A) 
10 
TABLE I 
THERAPEUTIC INDICES OF VARIOUS RETINOIDS 53 
Retinoids Hypervitaminosis A Antipapilloma T.l 
(mg/kg) effect (mg/kg) 
80 400 0.2 
400 800 0.5 
4 
50 25 2 
0.1 0.05 2 
11 
TABLE II 
RETINOID INHIBffiON OF MOUSE EPIDERMAL ODC INDUCTION AND TUMOR 
PROMOTION BY TPA 
Retinoid ODCAssay Antipapilloma Assay Reference 
IDso(nmol) IDso(nmol) 
Control 
~H 0.04 3.50 17, 45 
~ 4 C02H 1.40 64.00 17,45 
Ring Modified 




0.14 18 0.03 
4.00 18 
Heteroarotinoids 
~H 16 ~ 252.00 
I 
27 
~Et 0.70 18, 76 ~ 
I 
0 




The hamster tracheal organ culture (TOC) bioassay has been extremely valuable for 
providing information on retinoid structure-activity relationship.68 A number of synthetic 
retinoids have been examined in the TOC bioassay. In this bioassay, an organ culture 
system is employed that has the capacity for metabolizing the compounds, and thus the 
activity exhibited by retinoids may be due to the metabolites of that particular retinoid and 
not the retinoid itself.77 Introduction of two methyl groups at the C(4) position of the 
retinoic acid (3) (such as 26, Table III) blocks oxidative metabolism at this position and 
the activity drops by 50%.62 Acid 13 exhibited the highest activity of any retinoid 
screened in the TOC bioassay.l8 Removal of the two methyl groups from the C(5) 
position of 13led to acid 32 which showed less activity, thus suggesting the importance of 
the lipophilic moiety at that end. 62 The benzoic acid derivative 14 (Table III), with the 
polyene side chain partially replaced by an aryl ring, has only 5% of the activity of retinoic 
acid (3) at 100 fold higher concentration. 52 Ester 30 (Table III) of acid 14 has similar 
activity. In contrast, shifting the COzEt group from the para to the meta position (31, 
Table Ill) abolished the activity.l8 The activity increased when the phenyl ring in 14 was 
replaced by a thiophen ring (35, Table Ill), whereas when it was replaced by a furan ring 
(27, Table III), the activity diminished. In the case of heteroarotinoids, the introduction of 
benzopyran (33, Table Ill) reduced the EDso by over 1 log unit, compared to that of acid 
13, whereas in the case of the less polru: thiobenzopyran (29, Table Ill), the activity was 
reduced by 60%. The activity increased when the phenyl ring of acids 14 or 32 was 
replaced by a thiophene ring as in acid 35. 
The main hindrance to clinical utility of presently available retinoids is their 
toxicity.35 Thus, prolonged use of retinoids as chemopreventive or therapeutic agents is 
limited by their toxic side effects. Differences in metabolic degradation, distribution and 
the in vivo storage of various retinoids can lead to differences in toxicity which is one of 
the important reasons for synthesizing new analogues.9 The main symptoms of the hyper-
TABLEID 












Cone. M Active Total EDsoa, Reference 
Culture% 
10-1o 86 1 x w-11 62 
10-10 86 2 x w-11 62 
w-8 100 2 x w- 12 1s 
w-8 100 2 x w-10 s2 
10-1o 88 2 x w-11 62 
w-8 46 > 1 x w-8 16 





TABLE ill (Continued) 
TOCAssay 
Cone. M Active Total EDstfl, 
Culture% 
w-8 100 2 x w-10 
10-10 29 > 1 x w-8 
w-8 100 3 x w-11 
w-9 100 2 x w-10 
w-9 100 s x w-11 
w-8 









aThe activities are given as EDso; the estimated dose of retinoid required to reverse 
keratinization in 50% of the organ culture. 
15 
vitaminosis A syndrome in man involve changes in the skin such as cheilitis, desquamation 
pruntis, pigmentation and hair loss. 9 Other side effects include pain in the bones, joints 
and muscles as well as hepatic dysfunctions. Teratogenicity has been observed in animals 
and recently in humans exposed to 13-cis-retinoic acid (4).20 
Summary 
In conclusion retinoic acid (3) .plays an important role in cell differentiation and 
growth promotion.4,13 Recent studies have indicated that 3 is teratogenic and toxic in high 
doses. 53 It is evident that incorporation of the heteroatom into the retinoid skeleton does 
not reduce the activity by a wide range. More importantly, the heteroarotinoids are much 
less toxic than potent arotinoid TTNPB (13).18,70 Studies have also shown that more 
planar structures with ability to bind to receptors is probably a very important feature for 
more optimum retinoid activity.77 
CHAPTER II 
RESULTS AND DISCUSSION 
We have developed methodologies to synthesize several new heteroarotinoids and 
potential metabolites of heteroarotinoid 28. Heteroarotinoid 28 and possible metabolite~ 

















Figure 5. Structures of New Heteroarotinoids 45-47 with a 
Long Side Chain 
0 ) 
17 
A new group of heteroarotinoids with a long side chain was also prepared (Figure 5). 
18 
The compounds 36-44 can be classified as potential oxidative metabolites of ethyl (E)-4-
[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzopyran-6-yl)-1-propenyl]benzoate (28). Hetero-
arotinoid 28 had been synthesized in our laboratory and had been shown to possess good 
activity in several bioassays.19,76 
The potential metabolites 36-44 can further be classified into two groups, namely that 
obtainable from the oxidation of the allylic methyl group at C(12), as in compounds 36-39 
(Figure 3), and those in which the side chain has undergone oxidative cleavage as in 
compounds 40-44 (Figure 4). The products prepared as potential metabolites of 28 are, to 
some degree, reminiscent of those observed from trans-retinoic acid (3) and from the 
clinically-approved, synthetic arotinoid Etretinate (10) (see pages 5 and 6). It has been 
documented that retinoic acid (3) undergoes oxidative metabolism32 and some of the in 
vivo metabolites were found to be active whereas some were apparently produced for the 
purpose of excretion. 53 
Figure 5 shows the structures of new and novel heteroarotinoids which have a longer 
polyene side chain (compared to that in 28) and thus are possibly closer mimics ofretinoic 
acid (3). A sulfur atom has been sustituted for C( 4) in the cyclohexenyl ring of the retinoic 
acid (3), and a small part of the polyene side chain was condensed into an aromatic ring. 
These compounds were made by multi-step syntheses starting from commercially available 






Figure 6. Intermediates in the Syntheses of New Heteroarotinoids 48-55 
In order to investigate the potential metabolites obtainable from 28, it was decided to 
prepare labelled heteroarotinoid 28*. Figure 7 shows labelled compound 28* and the 
intermediates for the syntheses(* carbon atoms denote a 14C label introduced into 28*). 
In collaboration with Dr. Nelson and co-workers in the Biochemistry Department, a current 
investigation is underway to determine the pharmacokinetics and the major metabolites 
formed in vivo in rats given compound 28*. 















The ester 28 was synthesized according to Scheme I and as reported in the literature.76 
Pure 28 was obtained as white crystalline solid (95% ethanol), mp 72-73oC (lit76 mp 72.5-
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The approach to obtain potential metabolites 36-39 (page 16) utilized the parent 
compound 28 as starting material. Compounds 36-39 could be envisioned as accessible 
via successive oxidation of the allylic methyl at the C(12) first to hydroxymethyl 
derivatives 36 and 37, then to aldehyde 38, and finally to carboxylic acid 39. Of course, 
isomeric aldehyde Z-65 and acid Z-66 are conceivable from the procedures but were not 
22 
observed. 
A literature search and some·previous experience in the area of oxidation of this type 
of heterocyclic system suggested that SeOz might be the the reagent of choice for the 
oxidation of the C(l2) methyl group to the corresponding hydroxymethyl group. Indeed, 
that was the case as illustrated below. Both isomers 36 and 37 formed but, surprisingly, 
the major product isolated was the £-isomer 37 in which the two phenyl rings were syn to , 
each other. 
SeOzfEtOH/Ll 
This could be explained on the basis of the mechanism63 of oxidation with SeOz which 
involves a [2,3]-sigmatropic shift in one of the intermediates as shown below. Small 
quantities of the allylic alcohol 36 (Z-isomer), along with some aldehyde 38, were also 
detected. An oxidation experiment was carried out using 3 equivalents of the SeOz in 
boiling 95% ethanol with 28. Although allylic alcohol 37 was obtained in fair yield 
(31% ), increasing the reaction times or the number of equivalents of SeOz did not change 
23 





TheE-isomer 37 was purified on a 4 mm silica gel plate (Chomatotron) using a 
gradient elution with hexanes:ethyl acetate (8:2; 7:3) as eluents. Ester 37 was obtained as a 
thick, yellow-colored oil but all measures to convert it to a solid failed. The elemental 
analysis of the oil showed the presence of trace amounts of water which were retained even 
after prolonged heating under vacuum (llo·c, 10 mm Hg). However lH, nc NMR and 








TheE-isomer 37 was used as starting material for preparation of aldehyde 38. 
Treatment of 37 with activated Mn021 in CH2Cl2 at room temperature gave the 
corresponding aldehyde 38 (76%) which was isolated as a yellow-colored solid melting at 
157 -15s·c. Again in this reaction, the major product isolated was isomer 38 in which the 
two phenyl groups were syn to each other. 
Carboxylic acid 39 was obtained by direct oxidation of aldehyde 38 as shown. 
Various oxidizing reagents were employed in attempts to effect this latter conversion, 
including the conventional use of moist Ag2047 and Ni02 7, but the best results were 
obtained when the;unusual reagents shown were employed. Teatment of aldehyde 38 with 
i 
NaH2P04/NaCl02 in !-butanol gave acid 39 in a yield of 82%. Since Cl02 (the oxidant 
generated in this reaction) and CI- are formed in situ, resorcinol was added as a scavenger 
to limit further oxidation. 2 
Confirmation of all the products was established by UV, mass, 1 H NMR and Be 
NMR spectral analyses. A comparison of the UV maxima of stilbene and some of its 
derivatives, along with some arotinoids and heteroarotinoids, is given in Table IV. As can 
be seen from the Table, the £-isomers have a maxima with higher e values at long 
wavelengths whereas the Z-isomers have a maxima with higher e value at shorter 
wavelengths. Thus, it is implied that the £-isomers have greater conjugation and are 
probably more nearly planar. 
Another class of potential metabolites are 40-44 (page 17) in which the side chain of 
the parent compound 28 has undergone a C-C cleavage concommitant with some 
oxidation. The approach to these compounds originated from the 4,4-dimethylchroman 40 
which had been an intermediate in the synthesis of compound 2876 and could itself be a 
metabolite. Condensation of 40 with triethyl phosphonoacetate (67) using NaH{fHF 
yielded the a,~-unsaturated ester 41 isolated as a thick oil. The oil was purified on a silica 
gel plate (Chromatotron). Saponification of ester 41 with 4.3% alcoholic KOH gave, after 
TABLE IV 

















Amax. nm (£, x 104) Solvent 
228.8 (1.64) 95% EtOH 
224.0 (2.44) EtOH 
EtOH 
EtOH 
236.0 (1.40) EtOH 
237.0 (1.50) EtOH 
25 
26 
TABLE IV (Continued) 
Compound Conjugation Lower-wavelength 
band band 
Amax. nm (e, x 104) Amax' nm (e, x 104) Solvent 
310.0 (1.60) 245.0 (2.20) EtOH 
284.0 (1.16) 240.0 (1.41) 95% EtOH 
CHO 
330.0 (0.37) 286. 0 (1.47) 95%EtOH 
330.0 (0.66) 286.0 (1.28) 95% EtOH~ 
asuzuki, H. Bull. Chem. Soc. Jpn. 1960, 33, 379-388, 396-405. 
hMethyl (E) 4-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzopyran-6-yl-1-propenyl]benzoate 
(28a) (reference 27). 
cMethyl (Z) 4-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzopyran-6-yl-1-propenyl]benzoate 

















neutralization, acid 42. Acid 42 was obtained as a white solid after recrystallization 
(alcohol:water, 1:1). This acid retained traces of water in the crystals even after drying 
under vacuum for several hours. The mass spectral analysis, along with lH NMR and 13C 
NMR spectra, confirmed the structure of the acid 42 unambiguously. 
Another interesting metabolite, which has a structure similar to the metabolites 18 (page 
5) and 23 (page 6) obtained from trans-retinoic acid (3) and Etretinate (9), respectively, is 
that which contains a butyrolactone ring, namely 43. One method for the synthesis of this 
general type of system has been described by Corey and co-workers.12 In our example, 
28 
conversion of 40 to the homologated a,~-unsaturated aldehyde was the key initial step. 
Reaction of ketone 40 with (triphenylphosphoranylidene)acetaldehyde (68, Aldrich) did 
not generate the homologated aldehyde 69. A comprehensive literature search revealed an 
obscure example in the field of steroid chemistry wherein an unsaturated ester was 
converted to a lactone using Se02.l5 Treatment of a,~-unsaturated ester 41 with Se02 in 
boiling benzene resulted in the formation of lactone 43 in a one-pot reaction. The A-
butanolide derivative 43 is likely formed via initial oxidation of the allylic methyl group to a 
hydroxymethyl function which undergoes lactonization with concommitant loss of ethanol. 
After workup, lactone 43 was obtained as a thick oil which solidified upon trituration. 
Purification (95% ethanol) of the lactone gave a yellow-colored, crystalline solid melting at 
133-134°C, identified by spectral analyses (see Experimental). 
Carboxylic acid 44 was obtained as a white solid when methyl ketone 40 was treated 
with household bleach "Clorox" (5.25% NaOCl) mixed with 95% ethanol. The yield of 
44 was 67%. The simplicity of this method is an asset. 
In order to study the metabolism of the compound 28 in rats, it was decided to 
synthesize labeled 28* incorporating a 14C label at certain positions so as to facilitate a 
determination of the pattern of cleavage in vivo. Stratigically positioned 14C atoms or 
markers could also help in identification of metabolites via comparison with labelled 
' 
compounds synthesized as potential metabolites. The synthesis of 28* with 14C label at 
four different carbon atoms was achieved as illustrated (Figure 8). 
Methyl 3-phenoxypropionate (57) was prepared from commercially available 
3-phenoxypropionic acid (56). Treatment of 57 with two equivalents of H3l4CMg-I 
[prepared from H314CI (14C, 2.5 mg, 1 mCi, 56.6 mCi/rnmol sp.act., ICN) and Mg] gave 
the corresponding labelled tertiary alcohol 58*. Cyclialkylation of alcohol 58* in 
presence of anhydrous aluminum chloride in nitromethane produced 4,4-dimethylchroman 
59* with the 14C label at the gem-dimethyl groups. Acetylation of 59* was effected with 
H3C14C(O)Cl (1 mCi, 50 mCi/mmol, sp. act., ICN) and A1Cl3 to yield methyl ketone 
29 
40*. Reduction of 40* with LiAlR4 resulted in formation of secondary alcohol 60* with 
labels at three carbons. Phosphorylation of the alcohol with triphenylphosphine 
hydrobromide gave the phosphonium salt 61*. 
* * 
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Figure 8. Preparation of Heteroarotinoid 28* (a) MeOH, H+, CJI6, heat, Dean-Stark; 
(b) 1tH~gi, Ether; (c) AlCl3> CH3NOz; (d) H3C1t(O)Cl, 
A1Cl3> H3CNOz; (e) LiAlH.., Ether; (f) Ph~HBr, MeOH, Ether; 
(g) n-BuLi, Ether, 4-0HC-CJ-IitOpt (64) 
The 14C-labelled phosphonium salt was then mixed with some cold phosphonium salt, 
and the mixture was used in the Wittig condensation. In this final step, the anion generated 
from phosphonium salt 61* was treated with ethyl4-formylbenzoate [64*, 14C(O)OEt] at 
-78°C, and then the reaction was allowed to warm and stir for 24 hat room temperature. 
Purification of a yellow-colored oil obtained was achieved on a Chromatotron ( 4 mm silica 
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gel plate) using 200 mL of hexanes:ethyl acetate (9:1) as eluent. The bands with highest 
Rf values (0. 7 5 and 0. 7) were collected, and the solvent was evaporated to give a colorless 
oil. A solution of this oil in 95% ethanol was refrigerated to give the target labelled 
heteroarotinoid 28*. The specific activity was determined on a lOJ.LL aliquot of a solution 
(prepared by dissolving 7.3 mg of 28* in 4 mL of HPLC grade methanol) via the use of a 
TRI-CARB liquid scintillation analyzer. The specific activity of 28* was 0.15 mCi/mg or 
4.28 x lQ-5 mCi/mmol. An average count of 6043.8 DPM (disintegrations/minute) was 
obtained. This low activity must result from losses at one of more steps. Some use of 28* 
was possible by Dr. Nelson although reliance on UV spectral analysis to detect 28* was 
excellent at 1Q-4M and even lower concentrations. 
Aldehyde 64*, used in the last step to prepare 28* was synthesized from commercially 
available p-toluic acid-14C=O (62*, 0.5 mCi, 4.5 mCi/mmol sp. act., Sigma). 
Esterification of 62* with ethanol in presence of concentrated sulfuric acid, while 
removing the water as an azeotrope with benzene, gave ethyl p-toluate-14C=O (63*). 
Oxidation of ester 63* with Cr03 in acetic acid/acetic anhydride produced ethyl 4-formy-1 
benzoate 14C=O (64*).78 
* -C(O)OEt 
Ethanoi/C,HJA.. 0 I. CrD,!AI:.OH!Ac,_O 






We, in collaboration with Dr. Nelson of the Biochemistry Department, were able to 
identify certain metabolites from the bile of rats injected with 28. Identification of 
metabolites from 28 was done by comparing HPLC and the mass spectral profiles, as well 
as the UV spectra, with those obtained for synthesized potential metabolites. As can be 
seen from one region of the HPLC profile of bile and the HPLC profile of the standards, 
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Figure 9. HPLC Profile of (a) Section of Bile and (b) Standard Metabolites 
[C18 reverse phase (Whatrnan, ODS-3, 0.47 x 23.5 em), flow rate 
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Time (min) Time (min) 
Figure 10. HPLC Profile of Bile Sample Spiked With Standards (a) 37 and (b) 70 [C18 reverse phase (Whatman, ODS-3, 0.47 x 23.5 em), flow rate 
1 ml/min, at 22°C and 1600 psi, with 0.01M HOAc:MeOH (7:3)] 
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correspond to ester 37 and the acid 70, respectively (Figures 9 and 10). This was furthur 
confirmed by spiking the HPLC sample of bile with the standard compounds, and, as 
expected the peak height increased (Figure 10). Additional evidence for the presence of the 
compounds was obtained by comparison of the molecular ion in the mass spectra. The 
MH+• peak, in the case of ester 37, was seen at 367 m/z, whereas that in case of acid 70 
was seen at 323 mlz in both the standards and the fragments obtained from the bile. 
Another interesting study undertaken in collaboration with Dr. Nelson was to determine 
the nutritional value of heteroarotinoid 28 in comparison with that of retinoic acid (3). In 
this study, the gain in weight of rats whose diets were supplemented with or without ester 
28 or retinoic acid (3) was monitored over a period of 95 days. The rats were maintained 
initially on a vitamin A deficient diet until their weight plateaued. From this day (day 0), 
the rats were fed with diets supplemented with retinoic acid (3, in the case of control rats) 
or with compound 28 (in the case of test rats). As can be seen from the graphs (Figure 
11), growth with ester 28 paralleled that induced by trans-retinoic acid (3). Thus 28 could 
have some nutritional value and should be investigated more extensively. 
Syntheses Of New Heteroarotinoids 
In recent years the main objective of the researchers in the field of retinoids has been 
to synthesize compounds which would be close mimics of trans-retinoic acid (3), would 
exhibit good activity at low dose levels, and would be less toxic compared to 3. It has 
been shown with heteroarotinoids that the incorporation of a sulfur atom to replace C(4) 
reduces toxicity while maintaining good activity in several assays.69 We have prepared 
new heteroarotinoids 45-47 (page 17) which substitutes a sulfur atom for C(4) and may 
alter metabolism at that position.24 Part of the side chain has also been condensed into an 
z 
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Figure 11. Growth Curve For Retinoic Acid (3, Control Rat) 
and Heteroarotinoid 28 (Test Rat Fame) 
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aromatic ring thus restricting rotation along those' bonds and possibly making the structure 
more planar. A retro-synthetic approach to the basic skeleton for this compound can be 
envisioned as follows. 
R 
~~' ,OR > 
71 s 54 + OHC 
72 
ij 
0: < ~0 s s 52 
73 
An important intermediate in this multi-step synthesis was the thiaionone 52. With the 
thiaionone 52 in hand, conversion was effected to the corresponding alcohol 53, which, 
upon phosphorylation, could yield the phosphonium salt 54. Phosphonium salt 54 could 
then be condensed with various aldehydes under Wittig reaction conditions to give the 





A viable starting material for intermediate ketone 52 was 2,4,4-trimethylthiacyclo-
36 
hexan-3-one (73) which could be converted to 74. One possible route to ketone 52 
from 73 is as indicated below. As 2,4,4-trimethylthiacyclohexan-3-one (73) was not 
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s 52 
commercially available, a synthesis was developed, an initial approach is shown below as 
75 + 76.....,.77.....,.78.....,.79.....,.73.80 
CC02Me NaOMe/MeOH ., 
Cl HSCH2C02Me-





Condensation of methyl 4-chlorobutyrate (75) with methyl thioglycolate (76) gave diester 
77. Cyclization of 77 under Dieckmann conditions using NaOMe gave thia P-keto ester 
78 which was saponified and decarboxylated to thiacyclohexan-3-one (79). However, all 
attempts to alkylate thiacyclohexan-3-one (79) or P-keto ester 78 failed. In all cases either 
the starting material or a complex mixture was obtained from which no pure product could 
be isolated. 
Another approach to 73 was to condense methyl 2,2-dimethyl-4-chlorobutyrate (80) 
with methyl thioglycolate (76) which gave the corresponding diester 81 (68%). 
37 
Dieckmann cyclization of 81 with NaH gave P-keto ester 82 (53%). Saponification and 
decarboxylation of 82 was effected with concentrated sulfuric acid to give 4,4-
dimethylthiacyclohexan-3-one (83) (80%). Unfortunately, all attempts to generate 73 via 
monomethylation of 83 failed. 
a s .. X 
73 
It was decided to follow the multi-step approach of Huisman and co-workers3 to 
prepare 4-thiaionone (52). The synthetic pathway (Figure 11) illustrates the methodology. 
Ethyl acetoacetate (84), on treatment with dry H2S gas and dry HCl gas at -50 to -60°C, 
gave ethyl3-mercaptoacetoacetate (48, 62%). Ethy13-mercaptoacetoacetate was obtained 
as a mixture of cis- and trans-isomer of the thioketo tautomer as illustrated. Treatment of 
48 with freshly prepared NaOEt/EtOH produced the corresponding sodium salt which was 
condensed with 4-bromo-2-methyl-2-butene (85, Aldrich) in benzene to afford 2,6-
dimethyl-1-ethoxycarbonyl-3-thiahepta-1,5-diene (49, 65%) as a mixture of isomers. This 
ethyl ester was also obtained as a mixture of isomers which distilled under reduced 
pressure over a wide temperature range (75-125°C/0.4 mm Hg). This mixture of isomers 
was used in the next reaction without further separation. Reduction of the mixture of 
isomers of 49 with LiAIH4 in ether at -30oC gave the corresponding primary alcohol 50. 
38 
Alcohol 50 was used without purification as it appeared to undergo some type of structural 
rearrangement reactions upon standing. Oppenauer oxidation of 50 with 
Al[OCH(CH3)2l3, followed by in situ condensation with acetone, resulted in the formation 
of pseudo 4-thiaionone (51). Cyclization of 51 to 4-thiaionone (52) was carried out using 
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Figure 12. Preparation of Intermediates 48-54. (a) H~/ HCV-50°C; (b) NaOEt; 
EtOH/2,2-dimethyl-4-bromo-2-butene, (85); (c) LAH/Ether/-15oC; 
(d) Al[OCH(CH~ihlacetone/benzene/~; (e) H~OJH3CNOf-15°C; 
(t) LAH/Ether; (g) PPh3· HBr/MeOH/Ether 
4-Thiaionone (52) was present predominantly in the trans form as shown. Reduction of 
52 with LiAlH4 in ether afforded the corresponding secondary alcohol 53. 
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Phosphorylation with triphenylphosphine hydro bromide produced phosphonium salt 54 as 
a thick oil. This oil was then triturated with ether to give a yellow-colored solid. All 
compounds in this sequence, especially the phosphonium salt, were found to be extremely 
hygroscopic. 
Phosphonium salt 54 was used in a Wittig reaction with different aldehydes. In one 
reaction, the anion generated with n-BuLi from salt 54 was condensed with ethyl 4-
formylbenzoate (64) at -7s·c which, after 24 h of stirring at room temperature and work-
up, resulted in the formation of a yellow-colored oil. Chromatography of the oil on a 4 mm 
silica gel plate (Chromatotron), using hexane:ethyl acetate (9:1) as eluent, gave ethyl ester 




+ 0 n-BuLi/Ether/-78"C 
CHO 
64 
neutralization, gave a yellow-colored solid which was crystallized (95% ethanol) to give 
carboxylic acid 45 as light yellow solid. 
In order to study the effects on activity by different hydrophilic groups at the chain 
terminus, it was decided to use a highly polarized aldehyde in the Wittig condensation. 
Commercially available piperonal (87) was treated with the anion generated from the 
40 
phosphonium salt 54. After workup, the oil obtained was separated on a 4 mm silica gel 
plate using hexane:ether (9.5:0.5). Heteroarotinoid 46 was obtained as a mixture of 
isomers and all efforts to separate these failed 
Isomers 
The last target heteroarotinoid 47 was prepared by a Wadsworth-Emmons modification 
in the condensation step. 4-Thiaionone (52) was condensed with the anion of methyl 4-
diethylphosphonomethylbenzenesulfonate (55) to yield 47 (9%) as a crystalline solid. 
Sulfonate 47 permits a structure-activity assessment of the influence by S03Et versus 
COzEt. 
S03C2H5 
~ NruyTrnW48h ~ 
~ RT 
NBS/CC4 












Phosphonate 55 was prepared from methyl4-methylbenzenesulfonate (88) by initial allylic 
bromination to give methyl4-bromomethylbenzenesulfonate (89) which participated in a 
Michaelis-Arbuzov reaction involving triethyl phosphite (90). In this latter reaction both a 
rearrangement and a transesterification occurred since the product isolated was the triethyl 
sulfonate 55. Sulfonate 55 was a viscous, yellow-colored oil which was purified on the 
Chromatotron using hexane:ethyl acetate (8:2) as eluent. 
SMe 
54 
+ B{ SM 
PPh3 e 
+ 0 n-BuLi/Eiher/-78"<;,_ 




Another Wittig reaction of salt 54 was attempted with 4-methylthiobenzaldehyde (91). 
Rather than the expected thio ether 92, two major products were isolated. One was 
triphenylphosphine (93) in addition to a crystalline solid tentatively identified as 94. IR 
analysis showed the presence of the para-sustituted aromatic ring. The 1 H NMR spectrum 
of 94 had signals for five methyl groups at a 0.9, 1.3-1.45, 1.5-1.8 and 2.5, which are 
not in the exact region expected for 92. One can envision an intramolecular 
thermochemical cycloaddition reaction as shown to produce 94. Theoretically, one might 
54 + 91 94 
42 
expect a trans arrangement of the C-CH3 (bridgehead) and the C-C6H4SCH3 via a 
disrotatory closure. 
Ether 94 may be structurally related to certain natural products. Interesting systems 
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Suggestions For Future Work 
C02CH3 S~C02CH3 
~ 
We have prepared possible metabolites of 28 in which the side chain has undergone 
oxidation. Another site in 28 where oxidation can occur is at the gem-dimethyl position in 
the benzopyran ring. As can be seen from the metabolites obtained from trans-retinoic acid 
(3) and Etretinate (10), the methyl groups on the ring undergo oxidation to a 
hydroxymethyl group and a carboxylic acid. Thus, as shown below compounds, 97-99 
are likely metabolites from ester 28. 
X=O,S 
43 
0 TMSt:O CN co a I~ b Co X X ~ 
100 101 X 102 
ext 
l c 
co d ~ 0 X X 
104 103 
X=O,S 
Figure 13. Conversion of 100 to 104: (a) TMSCN/KCN/18-C-6/CH~l~ 
(b) TMSC1/Nal/CH3CN/Hexane/Water; (c) NaH!fHF/CH~; 
(d) AlClfCH3C(O)CVCH~02 
A possible route to these compounds is shown (Figure 13). Commercially available 
chromanone 100, (X = 0), upon treatment with TMSCN in CHzCl2 resulted in formation 
of cyanohydrin 101. Treatment of 101 with Nal in the presence of TMSCl and 
acetonitrile gave 4-cyanobenzopyran (102).61 Methylation of 102 under normal 
conditions formed 103. Acetylation of 103 gave 104 (X = 0) which, by selective 
reduction with Dibal-H at low temperature, should yield keto aldehyde 105 (Figure 14). 
Reduction of 105 with LAH could result in formation of diol 106, which, upon 
regioselective phosphorylation, should give phosphonium salt 107. This latter reaction 
has also been done in our lab in 5-membered heteroarotinoid family.27 A Wittig reaction 
with the anion of 107 and ethyl 4-formylbenzoate (64) should yield ester 97. Oxidation 
of 97 to aldehyde 98 and then to 99 should follow under mild conditions. To date, we 
have been able to obtain 104 (X = 0) via this reaction sequence. 
44 
ext OH(xt HOOd a ,~ 0 b ~ . OH 0 I . X X ~ X ~ 
104 105 106 
l c 









Figure 14. Suggested Syntheses of97-99: (a) DIBAL-H, -78°C-RT; (b) LAH, Ether, RT 
(c) PPh3·HBr, MeOH; (d) n-BuLi, Ether, -78°C, Ethyl4-Formylbenzoate 
(64); (e) Mn02, CH2Cl2; (t) Ag20, EtOH 
CHAPTER Ill 
EXPERIMENTAL 
General Information. Melting points were obtained on a Thomas-Hoover melting point 
apparatus and are uncorrected. IR spectra were recorded on a Perkin-Elmer 681 as KBr 
pellets or as films. All NMR spectra were taken on an Varian XL-300 spectrometer (with 
lH and 13C being observed at 299.94 and 75.43 MHz, respectively) and on an XL-400 
spectrometer (with 1 H and 13C being observed at 399.95 and 100.57 MHz, respectively), 
on solutions with DCCl3. Data are reported as follows: chemical shift (in o values or 
ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, qn = quintet, m = 
multiplet), coupling constant (in Hz), and assignment. Mass spectral data were recorded 
on a VG analytical instrument model ZAB-2SE. Elemental analyses were performed by 
Galbraith Laboratories, Knoxville, TN. Preparative chromatography was performed using 
Chromatotron (on silica gel PF2s4 containing gypsum, model 7924T, Harrison Research 
Inc., 840 moana Court, Palo Alto, CA 94306). TLC was performed on silica gel (Kodak 
chromatogram sheets, 132181 silica gel with fluoroscent indicator). 
Syntheses were executed, unless otherwise indicated, under an atmosphere of N2. 
The following reagents were obtained commercially and used without further purification: 
glacial acetic acid (Dupont), n-BuLi (Aldrich), t-butanol (Fischer), Se02 (Alfa), NaH 
(60%, dispersion in mineral oil, Aldrich), 15-crown-5 ether (Aldrich), triethyl 
phosphonoacetate (Aldrich), ethyl acetoacetate (Aldrich), H2S (g) (Aldrich), CH3I (14C, 
J 
ICN), CH3C(O)Cl [14C(O), ICN],p-toluic acid [14C(0)0Et, Sigma], methyl thioglycolate 
(Aldrich), methyl4-chlorobutyrate (Aldrich), 1-bromo-2-chloroethane (Lancaster), methyl 
45 
46 
p-toluenesulfonate (Aldrich), piperonal (Aldrich), N-bromosuccinimde (Alfa), potassium 
hydroxide (85%, Baker), and sodium hydroxide (97%, Baker). The following compounds 
required distillation prior to use: nitromethane (bp 1000C), TIIF (bp 65"C), and acetic 
anhydride (bp 138"C). 
Ethyl (E)-4-[2-(3,4-Dihydro-4,4-dimethyl-2H -l-benzopyran-6yl}-3-hydr-
oxy-1-propenyl]benzoate (37). A 100-mL, two-necked, round-bottomed flask was 
equipped with a magnetic stirrer and a condenser. To the suspension of 1.29 g (11.6 
mmol) of Se026 in 95% alcohol (30 mL) was added 1.35 g (3.85 mmol) of ethyl (E)-4-[2-
(3,4-dihydro-4,4-dimethyl-2H-1-benzopyran-6-yl)-1-propenyl]benzoate (28).76 The 
reaction mixture was boiled for 24 h. The new mixture was then cooled to room 
temperature, and black elemental Se was separated by gravity filtration. The residue was 
washed with 95% alcohol (10 mL). Evaporation (rotary evaporator) of the alcohol gave a 
residue which was dissolved in ether (50 mL). The ether layer was washed with water (1 x 
20 mL), saturated NaHC03 (1 x 20 mL), and finally with brine (1 x 30 mL). The organic 
layer was dried (Na2S04), filtered, and concentrated (rotary evaporator) to a light brown 
oil. Purification of this oil was accomplished by chromatography using the Chromatotron 
with a 4 mm silica gel plate. Gradient elution was effected using 100 mL of hexanes:ethyl 
acetate (95:5), 100 mL of hexanes:ethyl acetate (9.0: 1.0), 100 mL of hexanes:ethyl acetate 
(8.0:2.0), and finally with 250 mL ofhexanes:ethyl acetate (75:25). Different fractions (1 
to 20) of 20 mL each were collected. Fractions 16, 17 and 18 were combined, and the 
solvent was evaporated to afford 0.44 g (31.2%) of a very thick brown colored oil of ester 
37. IR (neat) 3650-3120, 1720 (C=O) cm-1; UV (EtOH) Amax 284.2 nm (E 1.16 x 104); 
lH NMR (DCCl3) o 1.15 [s, 6 H, H(9,10)], 1.35 [t, 3 H, H(22)], 1.61 [s, 1 H, OH], 
1.80 [m, 2 H, H(3)], 4.18 [m, 2 H, H(2)], 4.30 [q, 2 H, H(21)], 4.47 [s, 2 H, H(12)], 
6.67-7.8 [m, 8 H, Ar-H and C=CH]; 13C NMR (DCCl3) ppm 14.2 [C(22)], 30.4 [C(4)], 
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30.4 [C(9,10)], 37.3 [C(3)], 60.7 [C(21)], 63.1 [C(2)], 63.1 [C(l2)]; Ar-C and vinylic-C: 
117.3, 124.6, 127.9, 128.2, 128.9, 129.1, 129.2, 132.0, 141.7, 143.8, 153.4; 166.4 
[C(20)]. Unfortunately compound 37 retained trace amounts of water even after drying 
under vacuum for several hours. Anal. Calcd for C23H2604: C, 75.38; H, 7.15; Anal. 
Calcd. for C23H2604·0.25H20: C, 74:49; H, 7.15; Found: C, 74.10; H, 7.29. Mass 
spectral data calculated for C23H2604 mlz (M+·): 366.1831; Found: 366.1831. 
Ethyl (E)-4- [2-(3,4-Dihydro-4,4-dimethyl-2H -1- benzopyran-6-yl) -2- pro-
penal]benzoate (38). A 50-mL, single-necked, round-bottomed flask was equipped 
with a magnetic stirrer and a condenser. To 0.04 g (0.11 mmol) of ethyl (E)-4-[2-( 4,4-
dimethyl-3,4-dihydro-2H-1-benzopyran-6-yl)-3-hydroxy-1-propenyl]benzoate (37) in 15 
mL of CH2Cl2 was added 0.15 g (2.2 mmol) of activated Mn02.1 The reaction mixture 
was stirred at room temperature for 24 h and was then filtered. The residue was washed 
with 10 mL of CH2Cl2. The combined filtrate and washing were concentrated (rotary 
evaporator) to yield 0.03 g (76%) of a yellow-colored solid 38. The solid was crystallized 
(95% alcohol) to give yellow-colored crystals of ester 38, mp 157-158°C. IR (KBr) 
1725(C=0), 1680 cm-1; UV (EtOH) Amax 286.8 nm (e 1.48 x 104); lH NMR (DCCl3) () 
1.15 [s, 6 H, H(9,10)], 1.3 [t, J H, H(22)], 1.8 [m, 2 H, H(3)], 4.15 [m, 2 H, H(2)], 
4.30 [q, 2,H, H(21)], 6.72-7.85 [m, 8 H, Ar-H and -C=CH (13)], 9.7 [s, 1 H, H(12)]; 
13C NMR (DCC13) ppm 14.2 [C(23)], 30.5 [C(4)], 30.8 [C(9,10)], 37.3 [C(3)], 61.1 
[C(21)], 63.1 [C(2)]; Ar-C and vinylic-C: 117.4, 124.0, 128.1, 128.4, 129.4, 130.2, 
131.0, 132.0, 138.7, 143.0, 154.0; 165.8 [C(20)], 194.0 [C(l2)]. Anal. Calcd for 
C23H2404: C, 75.80; H, 6.64; Found: C, 75.64; H, 6.72. Mass spectral data calculated 
for C23H2404 mlz (M+·): 364.1668; Found: 364.1662. 
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Ethyl (E)-4- [2-(3,4-Dihydro-4,4-dimethyl-2H -1- benzopyran-6- yl)-2-pro-
panoic acid]benzoate (39). A 50-mL, two-necked, round-bottomed flask was 
equipped with a magnetic stirrer, a condenser, and an addition funneL To 0.035 g (0.096 
mmol) of ethyl (E)-4- [2- (3 ,4-dihydro-4,4-dimethy 1-2H -1- benzopyran -6-y 1)-2-
propenal]benzoate (38) and 0.012 g (0.11 mmol) of resorcinol in !-butanol (5 mL) was 
added a solution of 0.079 g ( 0.87 mmo1) of NaCl02 and 0.093 g (0.672 mmol) of 
NaH2P04 in water (10 mL).2 The reaction mixture was stirred at room temperature for 24 
h. Evaporation (rotary evaporator) of the solvent gave a residue to which was added water 
(25 mL), and the new solution was cooled (ice bath). This cold solution was acidified with 
6 M HCl (1 mL) to pH 1 (litmus). The aqueous solution was extracted with ether (3 x 25 
mL). The combined extracts were dried (Na2S04) and filtered, and the solvent was 
evaporated (rotary evaporator) to give 0.03 g (82%) of a yellow-colored oil. 
Crystallization was induced by scratching to give a solid. Recrystallization (absolute 
alcohol) of the solid gave yellow crystals of ester 39, mp 197-198·c. IR (KBr) 3600-
2850, 1740 (C=O), 1680 cm-1; UV (EtOH) Amax 286.2 nm (E 1.28 x 104); lH NMR 
(DCCl3) 8 1.18 [s, 2 H, H(9,10)], 1.36 [t, 3 H, H(22)], 1.82 [m, 2 H, H(3)], 4.21 [m, 2 
H, H(2)], 4.33 [q, 2 H, H(21)], 6.79-7.89 [m, 8 H, Ar-H and C=CH(13)]; 13C NMR 
(DCCl3) ppm 14.2 [C(22)], 30.5 [C(4)], 30.8 [C(9,10)], 37.4 [C(3)], 61.0 [C(21)], 63.1 
[C(2)]; Ar-C and vinylic-C; 117.3, 126.0, 128.5, 128.9, 129.3, 130.3, 130.4, 131.9, 
133.8, 139.2, 140.3, 153.7; 166.0 [C(20)], 172.7 [C(12)]. Anal Calcd for C23H2405 : 
C, 72.61 ; H, 6.36 ; Found: C, 72.36; H, 6.64. Mass spectral data calculated for 
C23H2405 mlz (M+·): 380.1623; Found: 380.1625. 
Ethyl 3-[3,4-Dihydro-4,4-dimethyl-2H -1- benzopyran-6-yl]crotonate 
(41). A 50-mL, two-necked, round-bottomed flask was equipped with a magnetic stirrer, 
a heating mantle and a condenser. To 0.212 g (5.39 mmol) of NaH (60% dispersion in 
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mineral oil washed with n-pentane 25 mL) in dry THF (10 mL) was added dropwise a 
mixture of 1.0 g (4.9 mmol) of 4,4-dimethylchroman-6-yl methyl ketone (40),76 1.21 g 
(5.39 mmol) of triethyl phosphonoacetate (67), and 0.10 g (0.454 mmol) of 15-crown-5 
in THF (10 mL) over a period of 10 min. The reaction mixture was stirred at room 
temperature for 24 h. It was then boiled for 2 h and allowed to cool to room temperature 
over a period of 24 h. This reaction mixture was acidified with glacial acetic acid (1 mL) to 
pH 6. Then a saturated solution of NaCl (50 mL) was added and the organic layer 
separated. The aqueous layer was extracted with ether (2 x 30 mL), and the combined 
extracts and the organic layer were washed with water (3 x 30 mL) and brine (30 mL). The 
organic layer was dried (NazS04), filtered and concentrated (rotary evaporator) to give 
1.03 g of reddish brown oil. The oil was purified by chromatography on the Chomatotron 
with a 4 mm silica gel plate using 50 mL of hexanes:ethyl acetate (95:5) and 200 mL of 
hexanes:ethyl acetate (9.0:1.0). Ester 41 was obtained as a thick oil (0.52 g, 38.7%). IR 
(neat) 1720 (C=O) cm-1; UV (EtOH) A-max 298.2 nm (E 1.39 x 104); lH NMR (DCCl3) () 
1.32 [t, 3 H, H(16)], 1.35 [s, 6 H, (CH3)2C], 1.84 [m, 2 H, H(3)], 2.55 [s, 3 H, H(12)], 
4.19 [q, 2 H, H(15)], 4.20 [m, 2 H, H(2)], 6.08 [s, 1 H, H(13)], 6.76 [d, J = 8.50 Hz, 1 
H, H(8)], 7.21 [dd, J = 8.47 Hz, J:::: 2.38 Hz, 1 H, H(7)], 7.40 [d, J = 2.33 Hz, 1 H, 
H(5)]; 13c NMR (DCC13) ppm 14.3 [C(16)], 17.7 [C(12)], 30.6 [C(14)], 30.9 [C(9,10)], 
37.4 [C(3)], 59.6 [C(15)], 63.6 [C(2)], 114.9 [C(8)], 116.9 [C(l3)], 125.0 [C(5)], 125.3 
[C(7)], 131.4 [C(6)], 134.0 [C(4a)], 154.6 [C(11)], 155.4 [C(8a)], 167.0 [C(14)]. Anal. 
Calcd for C17H2203: C, 74.43; H, 8.08; Found: C, 74.46; H, 8.00. Mass spectral data 
calculated for C17H2203 mlz (M+·): 274.1569; Found: 274.1566 
3-[3,4-Dihydro-4,4-dimethyi-2H -1-benzopyran-6-yl]crotonic Acid ( 42). 
A 50-mL, single-necked, round-bottomed flask was equipped with a magnetic stirrer, a 
heating mantle and a condenser. To 52 mg (0.19 mmol) of ethyl 3-[3,4-dihydro-4,4-
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dimethyl-2H-1-benzopyran-6-yl]crotonate (41) in 2 mL of absolute ethanol was added 5 
mL of H20 and 1 mL of 35 % (w/v) KOH. The solution was boiled for 5 hand then 
allowed to cool to the room temperature. It was further cooled in an ice bath (0-5°C) and 
was then neutralized with 6 M HCl (2 mL). A white solid formed and was filtered and 
washed with cold water. This solid was recrystallized [absolute alcohol/water (1:1)] to 
afford 35 mg (74.8%) of acid 42, mp 126-128oc: IR (KBr) 3500-3010, 1670 (C=O) 
cm-1; UV (EtOH) Amax 291.6 nm (E 1.30 x 104); lH NMR (DCCl3) 8 1.2 [s, 6 H, 
H(9,10)], 1.7 [m, 2 H, H(3)], 2.4 [s, 3 H, H(12)], 5.9 [s, l H, H(13)], 6.6-7.3 [m, 3 H, 
Ar-H]; 13C NMR (DCCl3) ppm 18.1 [C(l2)], 30.6.[C(4)], 36.9 [C(9,10)], 37.3 [C(3)], 
63.2 [C(2)], 114.1 [C(8)], 117.1 [C(13)], 125.2 [C(5)], 125.5 [C(7)], 131.5 [C(6)], 
133.8 [C(4a)], 155.0 [C(11)], 158.4 [C(8a)], 172.3 [C(14)]. Acid 42 retained traces of 
water even after drying under vacuum for prolonged period. Anal. Calcd for C1sHts03: 
C, 73.15, H, 7.37; Anal. Calcd. for C1sHts03·1/8H20: C, 72.51, H, 7.35; Found: C, 
72.42; H, 7.43. Mass spectral data calculated for C1sH1s03: mlz (M+·): 246.1256; 
Found: 246.1260. 
4-[3,4-Dihydro-4,4-dimethyl-2H -1- benzopyran-6-yl]~ 2-butenolide ( 43). 
A 50-mL, two-necked, round-bottomed flask was equipped with a magnetic stirrer, a 
heating mantle and a condenser. To 0.2 g (0.75 mmol) of ethyl 3-[3,4-dihydro-4,4-
dimethyl-2H-1-benzopyran-6-yl]crotonate (41) in dry benzene (25 mL) was added 0.41 g 
(3.70 mmol) of Se02.lS The reaction mixture was boiled for 20 h. After cooling the 
mixture to room temperature, the deposited metallic Se was separated by gravity filtration 
through a cotton plug. Water (25 mL) was added to the filtrate and the organic layer 
separated. The aqueous layer was extracted with ether (2 x 25 mL), and the combined 
extracts and organic layer were dried (Na2S04), filtered and concentrated (rotary 
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evaporator) to a thick yellow oil. Crystallization was induced by scratching to give 0.18 g 
(98.2%) of a yellowish, orange solid. The solid was recrystallized (95% alcohol) to give 
yellow crystals of 43, mp 133-134"C. IR (KBr) 1780, 1740 (C=O) cm-1; UV (EtOH) 
Amax 308.1 nm (£ 2.52 x 104); 1H NMR (DCCl3) B 1.36 [s, 6 H, H(9,10)] 1.86 [m, 2 H, 
H(3)], 4.26 [m, 2 H, H(2)], 5.19 [s, 2 H, H(l2)], 6.22 [s,l H, H(15)], 6.82 [d, J = 8.52 
Hz, 1 H, H(8)], 7.22 [dd, J = 8.46 Hz, J = 2.28 Hz, 1 H, H(7)], 7.39 [d, J = 2.28 Hz, 1 
H, H(5)]; Be NMR (DCCb) ppm 30.5 [C(4)], 30.7 [C(9,10)], 36.9 [C(3)], 63.4 [C(2)], 
70.9 [C(12)], 110.1 [C(15)], 118.0 [C(ll)]; Ar-C: 121.9, 125.3, 125.7, 132.5, 156.8; 
164.0 [C(l4)]. Anal. Calcd for C1sH1603: C, 73.75; H, 6.60; Found: C, 73.57; H, 
6.65. Mass spectral data calculated for C1sH1603 mlz (M+·): 244.1099; Found: 
244.1099. 
3,4-Dihydro-4,4-dimethyi-2H -1-benzopyran-6-carboxylic Acid (44). A 
50-mL, single-necked, round-bottomed flask was equipped with a magnetic stirrer, a 
heating mantle and a condenser. To 15 mL of commercially available Clorox solution 
containing 5.25% NaOCl was added 0.3 g (1.47 mmol) of 4,4-dimethylchroman-6-yl 
methyl ketone (40)76 in 95% alcohol (5 mL). The reaction mixture was stirred well and 
boiled for 1.5 h and then cooled to room temperature. This mixture was first neutralized 
with a 25% solution of sodium metabisulfite (25 mL) and then with concentrated HCl (2 
mL). A white solid formed and was filtered and then washed with cold water (50 mL) until 
the filtrate was free of acid. Recrystallization (95% alcohol) of the product afforded 0.2 g 
(67%) of white crystalline solid 44,8 mp 227-229"C. IR (KBr) 3400-2950, 1680 (C=O) 
cm-1; 1H NMR (DCCl3) B 1.37 [s, 6 H, H(9,10)], 1.85 [m, 2 H, H(3)], 4.27 [m, 2 H, 
H(2)], 6.83 [d, J = 8.62 Hz, 1 H, H(8)], 7.84 [dd, J = 8.67 Hz, J = 2.85 Hz, 1 H, H(7)] 
8.07 [d, J = 2.12 Hz, 1 H, H(5)]; Be NMR (DCCl3) ppm 30.59 [C(4)], 30.75 [C(9,10)], 
36.97 [C(3)], 63.49 [C(2)]; Ar-C: 117.1, 121.7, 129.5, 129.9, 131.5, 158.5; 171.8 
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[C(l1)]. Anal. Calcd for C12H1403: C, 69.87; H, 6.84. Found: C, 69.79, H, 6.67. 
Mass spectral data calculated for C12H1403 mlz (M+·): 206.0943; Found: 206.0943. 
4-[(AII-E}-2-methyl-4-(2,6,6-trimethyl-3-thia-1-cyclohexen-1-yl)-1,3-
butadienyl]benzoic Acid (45). A 100-mL, three-necked, round-bottomed flask was 
equipped with a magnetic stirrer, a rubber septum, and a condenser. To a stirred 
suspension of 0.5 g (0.93 mmol) of phosphonium salt 54 in ether (10 mL) was added 
dropwise 0.1 mL (1.0 mmol) of 10M n-BliLi solution. The resulting dark red-colored 
solution was stirred at room temperature for 15 min. This solution was then cooled to 
-78·c (dry ice/acetone bath) and to this was then added ethyl4-formylbenzoate (54). The 
solution was stirred at -78·c for 5 min and then allowed to warm to room temperature over 
a period of 24 h. Precipitated triphenylphosphine was separated and the filtrates were 
concentrated (rotary evaporator) to a yellow-colored oil. This oil was then transferred to a 
50-mL, round-bottomed flask and absolute ethanol (10 mL) was added, followed by 0.2 g 
of KOH in 10 mL of water. The solution was boiled for 90 min and then cooled to room 
temperature. It was then neutralized with 5% sulfuric acid (15 mL), and then the aqueous 
layer was extracted with ether (3 x 10 mL). The combined extracts were washed with brine 
(3 x 10 mL), then dried (NazS04), and concentrated (rotary evaporator) to give a yellow-
colored solid. This solid was crystallized (95% ethanol) to give 0.8 g (12%) of yellow-
colored crystalline solid 47 (mp 186-187.C). IR (KBr) 3500-3250 (OH), 1680 (C=O) 
'cm-1; lH NMR (DCCl3) o 1.1 [s, 6 H, (CH3)2], 1.85 [m, 2 H, H (3)], 1.9 [s, 3 H, CH3], 
2.1 [s, 3 H, CH3], 2.85 [m, 2 H, H (2)], 6.45-6.51 [m, 3 H, vinylic-H], 7.35 [d, 2 H, 
Ar-H], 8.05 [d, 2 H, Ar-H]; 13C (DCCl3) ppm 21.23 [C(9)], 22.02 [C(13)], 23.58 
[C(1)], 28.6 [C(7, 8)], 33.23 [C(2)], 38.8 [C(3)], 123.89, 126.81, 129.25, 129.83, 
130.08, 130.09, 133,45, 137.18, 143.44 [Ar-C and vinylic-C]; 170.80 [C(C=O)]. Anal. 
Calcd. for CzoHz40zS: C, 72.74, H, 7.52; Found: C, 73.13, H, 7.52. 
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5-[ (AII-E)-2-Methyl-4- (2,6,6-trimethyl-3-thia-1-cyclohexen-1-yl-1,3-
butadienyl]-1,3-benzodioxazole (46). A 50-mL, three-necked, round-bottomed 
flask was equipped with a magnetic stirrer, a rubber septum and a condenser. To a 
suspension of 1.5 g (2.7 mmol) of phosphonium salt 54 in ether (20 mL) was added 
dropwise 0.35 mL of a solution of 10M n-BuLi over a period of 10 min. The resulting 
red-colored solution was stirred at room temperature for 10 min and was then cooled to 
-78oC (dry ice/acetone bath) for 30 min. To the cold solution was added a solution of 0.41 
g (2.7 mmol) of piperonal (86) in ether (10 mL). The resulting solution was stirred at 
-78oC for 10 min and then allowed to warm to room temperature over a period of 24 h. 
Precipitated triphenylphosphine was separated (vacuum filtration), and the filtrates were 
collected and concentrated (rotary evaporator) to a light yellow-colored oil. This oil was 
separated on a 4 mm silica gel plate (Chromatotron) using hexane:ethyl acetate (9:1). The 
ftrst fraction was collected and concentrated to give 0.6 g of triphenylphosphine. The 
second fraction 100 mL was collected and concentrated to obtain 0.1 g (9%) of thick, light-
colored oil. The proton NMR spectrum of this oil showed the presence of several isomers 
and all efforts to separate these isomer using different solvent systems on silica gel and 
alumina TLC plates were unsuccessful. IR (neat) 1600 cm-1 (C=C); lH NMR (DCCl3) o 
1.1 [s, 3 H, gem-CH3], 1.8 [m, 2 H, H (2)], 1.9 [d, 3 H, CH3 (12)], 2.8 [m, 2 H, H 
(3)], 5.9 [s, 2 H, 0-CHz-0], 6.2-7.8 [m, 6 H, Ar-H and vinylic-H]. Anal. Calcd. for 
CzoH2402S: C, 73.13, H, 7.37; Found: C, 79.58; H, 5.72. Decomposition may occur 
readily with this compound in view of the unsatisfactory analysis. 
Ethyl 4-[(AII-E) -2-methyl-4- (2,6,6-trimethyl-3-thia-1-cyclohexen-1-yl)-
1,3-butadienyl]benzenesulfonate (47). A 100-mL, two-necked, round-bottomed 
flask was equipped with a magnetic stirrer and a condenser. To a suspension of 0.03 g 
(0.71 mmol) of NaH (60% dispersion in mineral oil) in THF (15 mL) was added 0.24 g 
(0.71 mmol) of ethyl 4-triethylphosphonomethylbenzenesulfonate (91) and 0.01g 
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(0.05 mmol) of 15-crown-5. The resulting solution was stirred at room temperature for 10 
min. To this stirred solution was then added 0.1 g (0.4 mmol) of 4-thiaionone 52 in TifF 
(10 mL) and the resulting red-colored solution was stirred at room temperature for 48 h. 
To this was added 1 mL of 6 M acetic acid and 10 mL of water. The resulting aqueous 
layer was extracted with ether (3 x 30 mL), and the combined extracts were washed with 
brine (50 mL). The aqueous layer was dried (Na2S04), filtered and concentrated (rotary 
evaporator) to give a dark-colored oil. This oil was separated on a 2 mm silica gel plate 
using hexane: ethyl acetate (95:5). The first fraction (100 mL) was collected and the solvent 
was evaporated to give 0.03 g (15%) of yellow-colored oil 47. IR (neat) 1550 (C=C) 
cm-1; lH NMR (DCCl3) o 1.2 [2 s, 6H, (CH3)2], 1.4 [t, 3 H, CH3CH2], 1.8 [m, 2 H, H 
(3)] 1.9 [d, 3 H, CH3], 2.1 [bs, 3 H, CH3], 4.2 [q, 2 H, CH2-CH3]. Anal. Calcd. for 
C21H2s03S2: C, 64.25; H, 7.19; Anal. Calcd. for C21H2s03S2·1/8H20: C 63.96; H 
7.19. Found: C, 63.88, H, 7.15. 
Ethyl 3-Mercaptocrotonate (48). A 1000-mL, three-necked, round-bottomed flask 
was equipped with a magnetic stirrer, a condenser and a gas inlet. A solution of 65 g (0.50 
mol) of ethyl acetoacetate (84) in 500 mL of dry CH3CN was cooled from -5o·c to -6o·c 
in a dry ice-chloroform bath (0.5 h). Then H2S gas was bubbled through the solution for 3 
h. After addition of the H2S gas, dry ~Cl gas was bubbled into the system via a steady 
stream for 4 h. The temperature of the reaction mixture was maintained between -5o·c and 
-6o·c (dry ice/chloroform bath).32 The color of the reaction mixture turned light orange. 
The reaction mixture was then poured into a mixture of cold water:petroleum ether (1:1, 
1000 mL). The organic layer was separated, and the aqueous layer was extracted 
(petroleum ether, 6 x 100 mL). The combined organics were dried (MgS04), filtered, and 
concentrated (rotary evaporator) to give 50 g of a red-colored liquid 48. The liquid was 
distilled under reduced pressure [bp 65-70.C/9 mm (lit3 bp 7TC/12 mm)] to obtain 45.0 g 
(62%) of isomers 48 (page 38). IR (neat) 2560-2400 (S-H), 1750-1680 cm-1(C=0) 
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cm-1; lH NMR (DCCl3) 8 1.3 (t, 3 H, CH3-CH2-), 2.3 (s, 3 H, CH3), 3.45 (s, 2 H, 
CH2), 4.2 (q, CH2-CH3). 
2,6-Dimethyl-1-ethoxycarbonyl-3-thia-1,5-heptadiene (49). A 500-mL, 
single-necked, round-bottomed flask was equipped with a Y-Claisen adapter bearing a 
condenser in the one arm and an addition funnel in the other. To freshly cut sodium (5.6 g, 
0.24 mol) in 100 mL of absolute alcohol was added another 100 mL of absolute alcohol in a 
steady stream so as to keep the reaction mixture boiling. After stirring for 0.5 h, 22 g (0.15 
mol) of ethyl 3-mercaptocrotonate (48) was added over a period of 10 min. The reaction 
mixture turned light yellow at the end of the addition. After being stirred at the room 
temperature for 0.5 h, the mixture was concentrated (rotary evaporator) to a light yellow 
semi-solid and benzene (200 mL) was added. To the stirred solution was added 20 g (0.13 
mol) of 4-bromo-2-methyl-2-butene (85) over a period of 10 min, after which time the 
reaction mixture became clear. This solution was stirred for 1 h at room temperature and then 
slowly added to cold water (500 mL). The organic layer was separated, and the aqueous 
layer was extracted (benzene, 6 x 100 mL). The combined organic layers were washed with 
water (4 x 100 mL), 6 M HCl (4 x 100 mL), saturated NaHC03 (2 x 100 mL) and finally 
with brine (100 ml). After the organics were dried (MgS04) and filtered, the solution was 
concentrated (rotary evaporator) to give 18.2 g (0.085 mol, 65%) of a yellow colored liquid 
which was distilled under reduced pressure [bp 75-125°C/0.4 mm (lit3 bp 75-
1230C/0.5mm)] to give a mixture of isomers of 49. IR (neat) 1740-1720 (C=O) cm-1; lH 
NMR (DCCl3), 8 1.3 (t, 3 H, CH3-CH2), 1.7 [d, 6 H, (CH3)2C], 2.5 (s, 3 H, CH3), 2.6 
(m, 2 H, CH2-S), 3.5 [m, 1 H, H(5)], 4.25 (q, 2 H, CH2-CH3), 5.05 [m, 1 H, H(l)] [lit3 
IR 1700 (C=O) cm·l for corresponding methyl ester]. 
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3,7-Dimethyl-4-thia-octa-2,6-dien-1-ol (50). A 300-mL, two-necked, round-
bottomed flask was equipped with a magnetic stirrer, an addition funnel and a condenser. 
The suspension of LiAlH4 (5.43 g, 0.143 mol) in ether (70 mL) was cooled in the ice bath 
(2 h), and then the temperature was brought to 0°C. To this cooled suspension was added 
18 g (0.084 mol) of 2,6-dimethyl-1-ethoxycarbonyl-3-thia-1,5-heptadiene (49) in 10 mL 
of ether over a period of 15 min. The reaction mixture was stirred at the same temperature 
for another 2 h. This reaction mixture was cooled to -30°C (in dry ice/acetonitrile bath, 1 
h), and water (50 mL), was added followed by 6 M HCl (20 mL). The organic layer was 
separated, and the aqueous layer was extracted (cold ether, 5 x 50 mL). The combined 
organics were dried (MgS04) at -300C, filtered, and concentrated (rotary evaporator) to 
give 13 g (89%) of the light yellow colored liquid 50 which was used immediately in the 
next step. IR (neat) 3550-3200 (0-H) cm-1 [lit3 IR 3390 (0-H) cm-1]. 
6,7-Dimethyl-7-thia-undeca-3,5,9-triene-2-one (51). A 2-L, round-bottomed 
flask was equipped with a magnetic stirrer, a heating mantle and a condenser. A mixture 
of 3,7-dimethyl-4-thia-octa-2,6-diene-1-ol (50, 13 g, 0.075 mol), aluminum isopropoxide 
(25 g, 0.122 mol) in 450 mL of acetone and 900 mL of benzene was brought to reflux and 
maintained at reflux for 36 h. The mixture changed from colorless to yellow. The new 
solution was then allowed to cool to the room temperature (1 h) and was washed with 
water (2000 mL), until the water washings were neutral, and then with 2000 mL of brine. 
The organics were dried (Na2S04), filtered and concentrated (rotary evaporator) to give 
12.2 gm ( 0.058 mole, 77%) of a light yellow-colored liquid 51. IR (neat) 1680 (C=O) 
cm-1; 1H NMR (DCCl3) o 1.7 (d, 6 H, (CH3)2C), 2.15 (d, 3 H, CH3), 2.29 (bs, 3 H, 
CH3-C=O), 3.45 (d, 2 H, CH2), 5.23 [m, 1 H, H(5)], 5.25 [m, 1 H, H(9)], 5.9-6.0 [m, 
1 H, H(4)], 7.4-7.45 [m, 1 H, H(3)] [lit3 UV (cyclohexane) Amax 328 nm (e 2.86 x 104)]. 
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4-Thia-8-ionone (52). A 300-mL, two-necked, round-bottomed flask was equipped 
with a condenser, a magnetic stirrer and an addition funnel. A solution of 30 mL of 
concentrated sulfuric acid in 40 mL of CH3N02 was cooled in dry ice/CC4 bath30 and the 
temperature was brought to -ls·c (30 min). A solution of 12 g (0.057 mol ) of 4-
pseudothiaionone (51) in 35 mL of CH3N02 was added dropwise over a period of 30 min. 
The color of the reaction mixture became dark red . This red-colored reaction mixture was 
stirred at -1s·c for an additional 1.5 hand then 'poured into 100 mL of ice water. The 
organic layer was separated and the aqueous layer was extracted (petroleum ether, 8 x 100 
mL). The combined organics were washed with brine (2 x 100 mL), dried (Na2S04), 
filtered, and concentrated (rotary evaporator) to give 8.0 g (0.038 mol, 67%) of a light 
brown colored liquid 52. IR (neat) 1650 (C=O) cm-1 [1it3 IR 1660 (C=O) cm-1]; 1H NMR 
(DCCl3), o 1.16 (s, 6 H, (CH3)2C), 1.8 (m, 2 H, CH2-CH2-S), 2.0 (s, 3 H, CH3), 
2.28(s, 3 H, CH3-C=O) 2.8 (m, 2 H, CH2-CH2-S ), 6.1 [d, J = 16.3 Hz, 1 H,H(4)], 7.3 
[d, J = 16.3 Hz, 1 H, H(3)]. 
4-Thia-8-ionol (53). A 500-mL, three-necked, round-bottomed flask was equipped 
with a condenser, a magnetic stirrer and an addition funnel. A suspension of 3.0 g (0.029 
mol) of LiAll4 in 100 mL of ether was cooled to O-s·c in an ice bath (30 min). To this 
cold, stirred suspension was added 4-thia-B-ionone (52, 8 g, 0.038 mol) in 50 mL of 
ether. The reaction mixture was stirred at O-s·c for 5 h, and then it was poured slowly 
onto 200 g of ice. Cautioq.sly, 30 mL of 6 M HCl was added to make the solution slightly 
acidic. The aqueous layer was extracted with ether (5 x 100 mL). The combined organics 
were washed with brine (2 x 100 mL), dried (Na2S04), filtered and concentrated (rotary 
evaporator) to give 5 g (0.023 mol, 62 %) of a reddish brown liquid 53. IR (neat) 3700-
3150 (0-H) cm-1; 1H NMR (DCCl3) o 1.05 (s, 6 H, (CH3)2C), 1.31 (d, J = 6.3 Hz, 3 H, 
CH3-CH), 1.85 (m, 2 H, CH2-CH2-S), 1.87 (s, 3 H, CH3), 2.83 (m, 2 H, CH2-CH2-S), 
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4.35 (m, 1 H, CH-OH), 5.4 [ dd, J = 15.87 Hz, J = 6.55 Hz, 1 H, H(4))], 6.04 [ d, J = 
15.87, 1 H, H(3)] [lit3 bp 85-90/0.1 mm for B-ionol]. 
4-Thia-8-cyclogernyltriphenylpbosphonium Bromide (54). A 250-mL, 
single-necked flask was equipped with a magnetic stirrer and a condenser. To a stirred 
solution of 5 g (0.023 mol) of 4-thia-B-ionol (53) in methanol was added 14 g (0.04 mol) 
of triphenylphosphine hydrobromide all at once, and the reaction mixture was stirred at 
room temperature for 24 h. Methanol was evaporated under reduced pressure (rotary 
evaporator), and the resulting thick, oily slurry was kept under vacuum (25.C/10 mm) for 
2 h. This oil was triturated with ether (100 mL) to obtain 13 g (0.024 mol) of a yellow 
solid 54. lH NMR (DCCl3) o 0.82 (s, 3 H, CH3), 0.91 (s, 3 H, CH3), 1.49 (dd, 3 H, 
CH3-CH), 1.3 (m, 2 H, CH2-CHz-S), 2.7 (m, 2 H, CHz-CH2-S), 3.2 (bs, 3 H, CH3), 
5.0 (m, 1 H, CH3-CH), 6.44 [m, 1 H, H(4)], 6.81 [m, 1 H, H(3)], 7.2-8.0 (m, 15 H, Ar-
H). 
2-Methyl-4-phenoxy-2-butanol-1,2 '.14c2 (58*). A 50-mL three-necked 
round-bottomed flask was equipped with a magnetic stirrer, a rubber septum and a cold 
finger. To 0.0698 g (2.91 mmol) of Mg turnings in (0.5 mL) of dry ether was added 
methyl iodide (14C, 2.5 mg, 1 mCi, 56.6 mCi/mmol sp. act., ICN) along with 10 mL of 
dry ether followed by the addition of 0.531 g (3.74 x lQ-3 mol) of H3Cl After stirring at 
room temperature for 30 min, the reaction mixture was treated with 0.150 g (8.32 x lQ-4 
mol) of methyl 3-phenoxypropionate (57) 76 in 5 mL of dry ether. After 24 h of stirring, 
the grey-colored reaction mixture was poured onto 20 g of crushed ice. Ether (20 mL) 
was added followed by slow addition of saturated NH4Cl solution (-40 mL). When the 
pH of the mixture was made neutral to litmus, the organic layer was separated. Extraction 
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(ether, 10 x 10 mL) of the aqueous layer followed. The combined organic layer and 
extracts were washed with water (3 x 10 mL), saturated NaHC03 (3 x 10 mL), and 
saturated NaCl (20 mL). After drying (NazS04) and filtering, the solution was 
concentrated to give 0.190 g (9.99 x 10-4 mol) of a light yellow-colored oil. This slightly 
impure 58* was used in the next step without further purification since all spectral 
properties were identical to those of the unlabelled material [lit76 IR 3~20-3140 (0-H) cm-1 
for the unlabelled compound]. 
4,4-Dimethylchroman-9,10-14C2 (59*). A 25-mL, three-necked round-
bottomed flask was equipped with a magnetic stirrer, an addition funnel and a condenser. 
To a suspension of 0.163 g (1.23 x 10-3 mol) of AlCl3 in 2 mL of freshly distilled 
H3CN02 was added 0.170 g (9.43 x 10-4 mol) of slightly impure 58* in 5 mL of freshly 
distilled H3CN02. After stirring for 24 h at room temperature, the dark red reaction 
mixture was cooled in an ice-water bath for a few minutes. Treatment with HCl (6 M, --10 
mL) to a pH acidic to litmus produced two layers. Stirring of the mixture continued for 10 
min and then ether (10 mL) was added. Extracts (ether, 10 x 10 mL) of the aqueous layer, 
combined with the original organic layer, were washed with water (5 x 10 mL), saturated 
NaHC03 (4 x 10 mL), and saturated NaCl (15 mL). After drying (NazS04), the solution 
was concentrated to a light brown-colored oil (0.160 g, 9.86 x 10-4 mol) which was 
slightly impure 59* via spectral analysis.76 This material was used without further 
purification in the synthesis of 40* [lit76 74-80°C/0.7 mm]. 
4,4-Dimethylchroman-6-yl Methyl Ketone-9,10,11-14CJ (40*). A 25-mL, 
three-necked, round-bottomed flask was equipped with a magnetic stirrer and a cold finger. 
To 1.57 mg (2 x10-5 mol, 1 mCi, 50 mCi/mmol sp. act., ICN) of H3Cl4C(O)Cl in 5 mL of 
freshly distilled H3CN02 was added 0.093 g (1.18 x 10-3 mol) of freshly distilled acetyl 
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chloride. To this solution was added 0.160 g (9.86 x 10-4 mol) of the above 4,4-
dimethylchroman (59*) in 10 mL of freshly distilled H3CN02. Slow addition of AlCl3 
(0.197 g, 1.48 x 10-3 mol) to the stirred solution followed. After stirring at room temperature 
for 10 h, the solution was cooled (ice-water bath). Cautious addition of of 6 M HCl (Ca 10 
mL) followed until the solution was just acidic to litmus. The combined organic layer and the 
ether extracts (10 x 10 mL) of the aqueous layer were washed with water (5 x 10 mL), 
saturated NaHC03 (3 x 10 mL), and saturated NaCl (15 mL). After this solution was dried 
(Na2S04), filtered, and concentrated, a light brown oil (0.165 g, 8.08 x 10-4 mol) remained. 
This slightly impure 40* showed the characteristic IR band for the C=O group (1650 cm-1) 
along with other spectral properties which confirmed the known structure.76 The sample 
of 40* was used without further purification [lit16 IR (neat) 1685-1675 (C=O) cm-1; lit55 
1670 (C=O) cm-1]. Since our preparation was slightly impure, the C=O values did not match 
exactly. 
a.,4,4-Trimethylchroman-6-methanol-9,10,11-14C 3 (60*). A 50-mL, two-
necked, round-bottomed flask was equipped with a magnetic stirrer and a condenser. To a 
stirred suspension of 0.042 g (1.10 x 10-3 mol) of LiAIH4 in 2 mL of dry ether was added 
ketone 40* from above in 5 mL of dry ether. The mixture was held at reflux for 24 h with 
about 15 mL of ether being added periodically to maintain volume. After the mixture was 
allowed to cool to room temperature, it was chilled (ice-water). Addition of 6 M HCl was 
performed until the mixture was slightly acidic to litmus. The combined organic layer and ether 
(10 x 10 mL) extracts were washed with water (5 x 10 mL), saturated NaHC03 (3 x 10 mL), 
and saturated NaCl (20 mL) solution. After the solution was dried (Na2S04), it was filtered 
and concentrated (rotary evaporator) to a thick brown oil which was slightly impure alcohol 
60* as_indicated by spectral analysis.80 The compound was used directly in the next step 
[lit76 IR (neat) 3640-3140 (0-H) cm-1 for the unlabelled compound 60]. 
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[1-(4,4-Dimethylchroman-6-yl)ethyl]triphenylphosphonium Bromide-
9,10,11-14C3 (61*). A 50-mL, single-necked, round-bottomed flask was-equipped 
with a magnetic stirrer and a condenser. A mixture of 0.120 g (5.82 x 10-4 mol) of 
alcohol 60* in methanol (25 mL) and 0.230 g (6.69 x 10-4 mol) of triphenylphosphine 
hydro bromide4 was stirred at room temperature for 24 h. Evaporation (rotary 
evaporator) of the methanol left a light brown oil which was triturated repeatedly with dry 
ether (-25 mL) until a solid formed. Filtration of the mixture provided a fair yield of 61 * 
(0.210 g, 3.95 x to-4 mol, 68%). TheIR spectrum of this salt 61* [149-153°C (dec)] 
was essentially identical to that reported for the unlabelled compound [lit76 mp 149-
155oC (dec)] and thus the former was used immediately in the final condensation to 
produce 28*. 
Ethyl (E)-4[2-(3,4-Dihydro-4,4-dimethyl-2H-l-benzopyran-6-yl)-1-prop-
enyl]benzoate-9,10,11,20-14C4 (28*). A 50-mL, two-necked, round-bottomed 
flask was equipped with a magnetic stirrer a condenser and a rubber septum. To a solution 
of n-butyllithium (1.5 mL of 1.0 molar in hexanes, Aldrich) was added to 0.200 g of 
phosphonium salt 60* (approximately 0.150 g of labelled material and 0.050 g of cold 
material) in dry ether (20 mL) over a period of 2 min. The resulting dark red mixture was 
cooled to -78°C (dry ice-acetone bath), and then 0.085 g (0.477 mmol) of ethyl 4-
formylbenzoate [4-0HC-C6H414CQ2Et] (64*) in ether (5 mL) was added. A cream-
colored mixture formed, and this was stirred at -78°C for 10 min and then was allowed to 
rise to room temperature with stirring over 24 h. A suspension formed and was filtered. 
The filtrate and one ether wash (25 rnL) of the filtered solid were combined and evaporated 
(rotary evaporater) to a yellow· oil. Chromatography of this oil was effected on a 
Chromatotron [ 4 mm plate, silica gel 60 PF254 containing gypsum] using 200 mL of 
hexanes:ethyl acetate (9:1) as eluent. Two bands with the highest Rfvalues (0.75 and 
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0.70) were collected, and the solvent was evaporated (rotary evaporator) in each case to 
give colorless oils. The oils appeared to be identical via TLC analysis and were combined 
and dissolved in a minimum amount of hot absolute ethanol (-5 mL). The solution stood at 
room temperature for 1 h, and then it was refrigerated (2 days). A white solid was 
deposited and this was filtered to obtain 13.2 mg (10%) of 28*. The specific activity was 
determined on a 10 J!L aliquot (prepared by dissolving 7.3 mg of 28* in 4 mL of HPLC 
grade methanol) via the use of a TRI-CARB liquid scintillation analyzer (model1900-CA, 
Packard Instrument Company, Downers Grove, IL). The specific activity of was 0.15 
mCi/mg or 4.28 x 10-s mCi/mmol. An average count of 6043.8 DPM 
(disintegrations/minutes) was obtained. A mixture melting point determination of this 
material with an authentic sample of cold 28 did not show a depression (mp 72-73°C).76 
Ethyl p-Toluate-14C=O (63*). A 50-mL, single-necked, round-bottomed flask 
was equipped with a magnetic stirrer, a heating mantle and a condenser. To a mixture of 
0.015 g (1.10 x 10-4 mol, 0.5 mCi, 4.5 mCi/mmol sp. act., Sigma) of p-toluic acid-
14C=0 (62*) and 0.290 g (2.13 x 10-3 mol) of p-toluic acid was added 10 mL of absolute 
alcohol and 20 mL of dry benzene along with 1 mL of cone. sulfuric acid. After boiling the 
solution for 24 h, the near theoretical amount of water was collected via a Dean-Stark trap. 
Water (-20 mL) was added to the solution which had been allowed to cool to room 
temperature. The combined organic layer and ether extracts (10 x 10 mL) were washed 
with water (3 x 10 mL), saturated NaHC03 (3 x 10 mL), and brine (20 mL). After the 
solution was dried (Na2S04), filtered, and concentrated (rotary evaporator), a light yellow 
liquid remained and was used immediately in the next step. The weight of the oil was 
0.380 g (quantitative). IR (neat) 1720 [broad] (C=O) cm-1 [lit76 IR (neat) 1745 (C=O) 
cm-1]-
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Ethyl 4~Formylbenzoate-14C(O )OEt (64*). A 25-mL, three-necked, round-
bottomed flask was equipped with a magnetic stirrer and a condenser. A solution of the oil 
63* (0.380 g, 2.31 x 10 -3 mol) in 5 mL of freshly distilled acetic anhydride and 5 mL of 
glacial acetic acid was cooled to ooc (ice-water bath). Concentrated H2S04 (0.2 mL) was 
added along with 0.693 g of Cr03 in three equal portions over a period of 30 min. Care 
was taken to maintain the temperature below soc during the addition. When the addition 
was complete, a dark green reaction mixture remained which was stirred for, 1 h at 0°C. 
Decomposition was effected by slowly pouring the mixture onto crushed ice (25 g) and 
then adding (very slowly) 50 mL of cold water. A green-colored solution formed, and this 
was extracted with HCCl3 (10 x 10 mL). The extracts were washed with water (3 x 10 
mL), 5% Na2C03 (3 x 10 mL), and brine (20 mL). The dried (Na2S04) solution was 
ftltered and concentrated to give 0.385 g of a yellow oil. Water (10 mL), 95% ethanol (10 
mL), and concentrated H2S04 (0.5 mL) were added, and the resulting solution was held at 
reflux for 1 h. After cooling to room temperature, the solution was diluted with water (10 
mL) and then extracted with HCCl3 (10 x 10 mL). The extracts were washed with water (3 
x 15 mL), 10% NaHC03 (3 x 10 mL), and brine (20 mL). When dried (Na2S04), the 
solution was filtered and concentrated (rotary evaporator) to give 0.090 g (36.8%) of 64* 
which was used in the Wittig reaction with the anion from salt 61 * to yield 28*. IR 
(neat) 1725 [broad] C(=O)OEt and (HC=O) [lit76 IR (neat) 1740 C(=O)OEt, 1680 
(HC=O) cm-1]. 
Methyl 4-(Carboxymethylmercapto)butyrate (77). A 25-mL, three-necked, 
round-bottomed, flask was equipped with a magnetic stirrer, a rubber septum and a 
condenser. Into this system was placed MeOH (5 mL), which was cooled to 0-5oC (ice-
water bath), and then 1.03 g (19.1 mmol) ofNaOMe was added in two portions over a 15-
min period. Methyl thioglycolate (76, 2.00 g, 18.8 mmol) was added by syringe to this 
64 
cold, stirred solution, and the reaction mixture was stirred at 0-5°C for 15 min. Methyl4-
chlorobutyrate (75, 2.50 g, 18.24 mmol) was added by syringe, and the resulting reaction 
mixture was stirred at the same temperature for 10 min. It was then allowed to warm to the 
room temperature over a period of 3 h. The reaction mixture turned cloudy over this 
period. It was allowed to stand overnight, and solid NaCl precipitated which was filtered 
(gravity). The residue was washed with MeOH (25 mL). The filtrates and washings were 
combined and evaporated (rotary evaporator) to yield a viscous residue which was 
dissolved in 20 mL of ether:water (1:1). The organic layer was separated, washed with 
water (2 x 10 mL), dried (MgS04), filtered, and concentrated (rotary evaporator) to give a 
colorless liquid 77 (3.29 g 87%). IR (neat) 1740 (C=O) cm-1 [1it80 1740 broad (C=O) 
cm-1 ]; 1 H NMR (DCCI3) B 1.94 [m, 2 H, H(3)], 2.44 [t, 2 H, H(2)], 2.68 [t, 2 H, 
H(4)], 3.23 [s, 2 H, H(6)], 3.68 [s, 3 H, H(8)], 3.74 [s, 3 H, H(9)]; Be NMR (DCCI3) 
ppm 29.93 [C(3)], 31.71[C(2)], 32.51[C(4)], 33.09 [C(6)], 51.55[C(8)], 52.31 [C(9)], 
170.75 [C(l)], 173.27 [C(7)]. 
2-Carbomethoxythiacyclohexan-3-one (78). A 25-mL, two-necked, round-
bottomed flask was equipped with a magnetic stirrer, condenser, and an addition funnel. A 
suspension of 1.05 g (0.019 mol) of NaOMe in ether (10 mL) was added with stirring and 
cooling to 0-5°C in ice bath. To this stirred suspension was added 2.00 g (0.096 mol) of 
methyl 4-(carboxymethylmercapto)butyrate (77). The thick, yellow-colored suspension 
was stirred at 0-5°C for 1 h a'nd then was allowed to warm to room temperature over a 
period of 3 h. Water (10 mL) and glacial acetic acid (4 mL) were slowly added to the 
reaction mixture. The organic layer was separated, and the aqueous layer was extracted 
with ether (10 mL). Combined organics were washed with saturated NaHC03 (3 x 10 
mL) and with brine (10 mL). The organics were dried (MgS04), filtered and concentrated 
(rotary evaporator) to give 1.03 g of the colorless liquid 78. IR (neat) 1740, 1720 (C=O 
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ester free and hydogen bonded), 1660 (C=O ketone) cm-1[1it80 1745, 1715, 1645 (C=O, 
ester and ketone) cm-1]; 1H NMR (DCCl3) o 2.13 [m, 2 H, H(5)], 2.40 [t, 2 H, H(4)], 
2.81 [t, 2 H, H(6)], 3.69 [s, 1 H, H(2)], 3.81 (s, 3 H, CH3), 12.1 (s, 1 H, OH). 
Attempted Alkylation of 78. A 100-mL, three-necked, round-bottomed flask was 
equipped with a magnetic stirrer, a condenser and a rubber septum. A suspension of 0.173 
g (0.007 mol) of NaH (50% dispersion in mineral oil) in 40 mL of dry benzene was cooled 
to 0-5°C (ice bath). To this cold stirred suspension was added 0.270 g (0.0014 mol) of 2-
carbomethoxythiacyclohexan-3-one (78). A gas was observed to form in the suspension. 
The mixture was stirred at 0-5°C for 30 min, and then 3.06 g (0.027 mol) of CH3I was 
added slowly by syringe. The mixture was stirred at same temperature for 10 min and then 
allowed to warm to the room temperature over a period of 36 h. It was then cooled in ice 
bath and MeOH (10 mL) and water (10 mL) were added. The organic layer was separated 
and the aqueous layer was extracted with ether (3 x 10 mL). The combined organic 
solutions were dried (Na2S04), filtered and concentrated (rotary evaporator) to give 0.075 
g of a yellow colored oil 78. This oil was similar to the starting material as it had IR bands 
at 1740, 1715, 1640 cm-1. This reaction was carried out with 4-6 equivalents of CH3l, 
but the result was similar in all cases. lH NMR (DCCl3) o 2.13 [m, 2 H, H(5)], 2.40 [t, 2 
H, H(4)], 2.81 [t, 2 H, H(6)], 3.69 [s, 1 H, H(2)], 3.81 (s, 3 H, CH3). 
Methyl 4-Chloro-2,2-dimethylbutyrate (80 ). A 300-mL, three-necked, round-
bottomed flask was equipped with an addition funnel, rubber septum and a condenser. 
Freshly distilled diisopropylamine (10.12 g, 0.001 mol) in 50 mL of THF was cooled to 
-78°C (dry ice-acetone bath), and then 10 mL of a 10M solution of n-BuLi was added 
dropwise by syringe. The resulting yellow-colored solution was stirred at -78°C for 1 h. 
Methyl isobutyrate (8.17 g, 0.001 mol, Aldrich) was then added over a period of 10 min, 
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and stirring was continued at same temperature for 1 h. After this time, 15.0 g ( 0.0015) of 
1-bromo-2-chloroethane (Lancaster) in 25 rnL of THF was added over a period of 15 min. 
After stirring for an additional10 min at -78°C, the reaction mixture was allowed to warm 
to the room temperature over a period of 24 h. A solid formed and was filtered off. The 
solid melted at 142-144oC and weighed 500 mg; no further work was done with this solid. 
It was then cooled in an ice bath, and water (100 rnL) was added followed by concentrated 
HCl (25 rnL). The organic layer was separated and washed with 10% HCl (2 x 50 rnL). 
The combined aqueous layer was extracted with CH2Cl2 (3 x 100 rnL). The original 
organic layer, along with the organic extracts, were dried (Na2S 04), filtered, and 
concentrated (rotary evaporator) to give a colorless liquid 80 which was distilled under 
vacuum (bp 47-50°C/8 mm, 1it8 bp 80-84°C/15 mm). 
Methyl 2,2-Dimethyl-4-(methoxycarbonylmethylmercapto)butyrate (81). 
A 50-mL, two-necked, round-bottomed flask was equipped with a magnetic stirrer, a 
heating mantle and a condenser. To a solution of 1.67 g (0.03 mol) of NaOMe in MeOH 
(25 rnL) was added dropwise 3.29 g (0.03 mol) of methyl thioglycolate (76, Aldrich). 
The reaction mixture was boiled for 0.5 h and then cooled to the room temperature. In an 
another 100-rnL, round-bottomed flask equipped with an addition funnel, condenser and 
heating mantle was placed a solution of 5 g (0.03 mol) of methyl 2,2-dimethyl-4-
chlorobutyrate (80) in 25 rnL of MeOH. To this was added the earlier reaction mixture of 
the sodium salt of the methyl thioglycolate (page 37) over a period of 30 min. The new 
reaction mixture was boiled for 24 hand then was cooled to the room temperature (1 h). 
The MeOH was evaporated (rotary evaporator). The residue was poured slowly onto ice, 
and the aqueous solution was acidified with 6 M HCl (15 rnL) to a pH of about 6. The 
acidic aqueous solution was extracted with ether ( 4 x 25 mL). The combined organic 
extracts were dried (Na2S04), filtered and concentrated (rotary evaporator) to give a light 
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yellow-colored liquid 81 which was distilled under vacuum (bp 112-115°C/0.02 mm, 1it3 
bp 114-llTC/0.25 mm). IR (neat) 1740-1720 (C=O) cm-1. 
2-Carbomethoxy-4,4-dimethylthiacyclohexan-3-one (82). A 25-mL, two-
necked, round-bottomed flask was equipped with a magnetic stirrer, a heating mantle and a 
condenser. To a boiling suspension of 0.344 g of NaH (60% dispersion in mineral oil) in 
benzene (10 mL) was added 1.0 g (0.004 mol) of methyl 2,2-dimethyl-4-
carboxymethylmercaptobutyrate (81). The reaction mixture was boiled for 4 h. It was 
then cooled to the room temperature and poured onto ice. The resulting mixture was made 
acidic with 6 M HCl (10 mL) to a pH of about 6. The aqueous layer was extracted 
(benzene, 4 x 10 mL), and the combined extracts were dried (Na2S04), filtered, and 
concentrated (rotary evaporator) to give 0.8 g of an orange-colored liquid 82. 
Chomatography on a 2 mm silica gel plate (Chomatotron) with 50 mL of hexane:ethyl 
acetate (9:1), followed by 50 mL of hexane:ethyl acetate (8:2) as eluent, gave several 
fractions. The first fraction of 50 mL was collected and concentrated to give 0.32 g of a 
colorless liquid 82. IR (neat) 1730-1645 (C=O) cm-1 [lit3 IR 1735-1644 (C=O) cm-1]; 
1H NMR (DCCl3) o 1.2 [s, 6 H, (CH3)2], 1.98 [m, 2 H, H(5)], 2.8 [m, 2 H, H(6)], 3.8 
(s, 3 H, OCH3), 12.4 [s, 1 H, OH (enol tautomer)]. 
Attempted Reaction of 82 with N-Phenyltrifluoromethanesulfonimide. A 
25-mL, two-necked, round-bottomed flask was equipped with a magnetic stirrer, 
condenser and a rubber septum. A solution of 0.110 g (0.001 mol) of freshly distilled 
diisopropylamine in 5 mL- of mF was cooled to -78°C (dry ice/acetone bath), and 0.11 mL 
(0.0011 mol) of n-BuLi (10 M solution in hexane) was added by syringe. The reaction 
mixture was stirred at -78oC for an additional10 min, and then 0.2 g (0.99 x w-3 mol) of 
thia 8-keto ester 82 was added in 5 mL of THF by syringe. The resulting mixture was 
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stirred at the same temperature for 2 h. After this period, 0.378 g (0.0011 mol) of N-
phenyltrifluoromethanesulfonimide (Aldrich) in 3 mL of THF was added over a period of 5 
min. After the addition was complete, the cold bath was removed and the reaction mixture 
was stirred overnight. Evaporation (rotary evaporator) of the solvent gave a residue which 
was dissolved in 10% HCl (10 mL). The aqueous layer was extracted with pentane (4 x 10 
mL). Combined extracts were washed with 10% HCl (15 mL), 10% NaOH (15 mL) and 
water (10 mL), after drying (Na2S04), the solution was filtered and evaporated (rotary 
evaporator) to give 0.15 g of white crystalline solid which showed spectral properties 
similar to N-phenyltrifluoromethanesulfonimide, and the mp of N-phenyltrifuoromethane 
sulfonimide was 99-101 °C. The mp of the solid was foun4 to be 100-101 oc. 
4,4-Dimethylthiacyclohexan-3-one (83). A 50-mL, two-necked, round-
bottomed flask was equipped with a condenser, a magnetic stirrer and a heating mantle. A 
solution of 2.00 g (9.89 X 10-3 mol) Of 2-carbomethoxy-4,4-dimethylthiacyclohexan-3-one 
(82) in 15 mL of 10% H2S04 was boiled for 6 h. The yellow solution was first cooled to 
the room temperature and then slowly neutralized with 10% NaOH (ca 20 mL) to pH 7. 
The aqueous layer was extracted with ether (3 x 25 mL). The combined organics were 
dried (Na2S04), filtered and evaporated (rotary evaporator) to give a light yellow colored 
liquid 83. IR (Neat) 1705 (C=O) cm-1 [1it3 1705 cm-1 (C=O)]; 1H NMR (DCCl3) B 
1.15 [s, 6 H, (CH3)2], 2.2 [m, 2 H, H(6)], 2.8 [m, 2 H, H(5)], 3.2 [s, 2 H, H(2)]. 
Attempted Alkylation of 4,4-Dimethylthiacyclohexan-3-one (83). A 100-
mL, three-necked, round-bottomed flask was equipped with a magnetic stirrer, a rubber 
septum and a condenser. A solution of 0.7 g (6.92 x 10-3 mol) of freshly distilled 
diisopropylarnine in 10 mL ofTHF was cooled to -78 oc (dry ice/acetone bath), and to this 
cooled solution was added 0.7 mL of 10M solution of n-BuLi in hexane by syringe. The 
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resulting yellow-colored solution was stirred at -7s·c for 30 min, and then 0.9 g (6.24 x 
w-3 mol) of 4,4-dimethylthiacyclohexan-3-one (83) in 5 mL of THF was added dropwise 
by syringe. After stirring for 30 min, 0.9 g (6.37 X w-3 mol) of CH3l in 5 mL of THF 
was added over a period of 2 min. After the addition was complete, the cold bath was 
removed, and the reaction mixture was allowed to warm to room temperature over a period 
of 24 h. After this time, the reaction mixture was cooled in an ice bath and was then 
quenched with water (10 mL), followed by 6 M ,ac1 (5 mL) to a pH of about 3. The 
aqueous layer was separated and extracted with ether (3 x 25 mL). The combined organics 
were dried (Na2S04), filtered and concentrated to give a dark oil, which showed spectral 
properties similar to the starting ketone [1it3 IR 1705 cm-1 (C=O)]. Thus it was concluded 
that the alkylation did not take place. This reaction was repeated with 2-4 equivalents of 
CH3l, but the end result was the same. 
Methyl 4-Bromomethylbenzenesulfonate (89). A 50-mL, single-necked, 
round-bottomed flask was equipped with a magnetic stirrer, a heating mantle, and a 
condenser. To a boiling solution of 5.0 g (0.02 mol) of methyl p-toluene sulfonate (88) in 
CC4 (25 mL) was added a mixture of 4.98 g (0.03 mol) of N-bromosuccinirnide and 0.01 
g of dibenzoyl peroxide over a period of 45 min. The resultng brown-colored solution was 
boiled for 5 h and then cooled to room temperature. Precipitated succinamide was filtered 
(vacuum) and washed with 25 mL of CCl4. Combined washings and filtrate were 
concentrated to give 5.6 g (75%) of white solid. This solid was used without furthur 
purification in the next step. lH NMR (DCCl3) o 3.9 (s, 3 H, -OCH3), 4.5 (s, 2 H, CH2-
Br), 7.5 (d, 2 H, Ar-H), 7.9 (d, 2 H, Ar-H). 
Ethyl 4-triethylphosphonomethylbenzenesulfonate (91). A 150-mL jacketed 
flask was equipped with a magnetic stirrer, two condensers, a heating mantle, and toluene 
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in outer jacket. The mixture of 5.0 g (0.02 mmol) of crude 89 and 4.74 g (0.03 mmol) of 
triethyl phosphite (90) was kept at boiling point of toluene (110°C) for 6 h. The resulting 
pink-colored solution was cooled to room temperature and then was separated on a 4 mm 
silica gel using hexane:ethyl acetate (8:2). The third fraction of 150 mL was collected and 
solvent was evaporated to give 2.1 g (48%) of light-colored oil91. IR (neat) 1250 cm-1 
(P=O). The compound was used directly in the preparation of 47. 
4-Cyano-4-trimethylsilyloxy-3,4-dihydro-2H -1-benzopyran (101). A 50-
mL, two-necked, round-bottomed flask was equipped with a magnetic stirrer and a 
condenser. To 1.5 g (10 mmol) of 4-chromanone (100) in 10 mL of CH2Cl2 was added 
15 mg (0.23 mmol) of KCN and 15 mg (0.05 mmol) of 18-crown-6 ether. This reaction 
mixture was cooled in an ice bath and then 1.19 g (12 mmol) ofTMSCN was added. The 
reaction mixture was stirred at ooc for 10 minutes and was then allowed to warm to room 
temperature over a period of 24 h. The color changed from light yellow to dark, reddish-
brown over this period. The reaction mixture was diluted with CH2Cl2 (10 mL). The 
organics were washed with water (2 x 20 mL), saturated NaHC03 (2 x 20 mL) and with 
brine (20 mL). It was dried (Na2S04), filtered and evaporated (rotary evaporator) to 2.1 g 
(85 %) brown colored liquid. IR (neat) 3110 cm-1;1H NMR (DCCl3) B 0.2 [s, 9 H, 
Si(CH3)], 2.4 [m, 2 H, H(3)], 4.35 [m, 2 H, H(2)], 6.8-7.6 [m, 4 H, Ar-H]; 13c NMR 
(DCCl3) ppm 1.12 [C(Si(CH3)3)], 36.19 [C(2)], 61.2 [C(3)], 117.4 [C(CN)]; Aromatic-
C 120.6, 120.7, 120.9, 128.6, 131.2, 153.4. 
4-Cyano-3,4-dihydro-28 -1-benzopyran (102). A 100-mL, two-necked, 
round-bottomed flask was equipped with a condenser and a magnetic stirrer. To a mixture 
of 3.91 g (36 mmol) of TMSCl, 1.48 g (36 mmol) of CH3CN, and 5.39 g (36 mmol) Nal 
was added 1.5 g (6.07 mmol) of 4-cyanochroman (101) in 10 mL of hexane. The reaction 
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mixture was stirred (30 min) and then 0.22 g of water was added. This heterogeneous 
mixture was stirred at room temperature for 24 h. The color of the aqueous layer changed 
to dark red. After 24 h, water (10 mL) was added and the organic layer was separated. 
The aqueous layer was extracted with ether (3 x 25 mL), and the combined organics were 
washed with water (2 x 15 mL), 10 % Na2S203 (3 x 25 mL), and brine (30 mL). It was 
dried (Na2S04), filtered, and evaporated (rotary evaporator) to dark brown-colored liquid. 
After purification on the Chromatotton with 200 mL of hexanes:ethyl acetate (9: 1), 0. 7 g 
(70 %) of light yellow colored liquid was obtained. IR (neat) 2220 cm-1; 1H NMR 
(DCCl3) 8 2.4 [m, 2 H, H(3)], 4.0 [m, 1 H, H(4)], 4.3 [m, 2 H, H(2)], 6.8-7.4 [m, 4 H, 
Ar-H]; 13c NMR (DCCl3) ppm 26.1[C(3)], 26.8 [C(4)], 63.5 C(3)]; 117.7 [C(CN)]; 
Aromatic C 115.1, 120.4, 121.2, 129.3, 129.9, 154.0. 
4-Cyano-4-methyl-3,4-dihydro-2H -1-benzopyran (103). A 50-mL, two-
necked, round-bottomed flask was equipped with a magnetic stirrer and a condenser. To 
the suspension of 0.12 g (4.84 mmol) of NaH in 10 mL of THF was added 0.7 g of 4-
cyanochroman (102). The color of the reaction mixture turned dark orange, and after 
stirring for 15 minutes, 0.68 g of CH3I was added by a syringe. The resulting reaction 
mixture was stirred at room temperature for 24 h. It was cooled in an ice bath (15 
minutes), and then water (10 mL) was added followed by 5 mL of 10% HCl (pH 5). The 
organic layer was separated and extracted with ether (3 x 20 mL). The combined organics 
were washed with water (3 x 25 mL) and brine ( 40 mL). The organic layer was dried 
(Na2S04), filtered and evaporated (rotary evaporator) to give dark brown-colored liquid. 
This liquid was purified on a 4 mm chromatotron plate using 200 mL of hexane:ethyl 
acetate (9:1) to afford 0.48 g (61 %) of a dark colored liquid. IR (neat) 2220 cm-1; 1H 
NMR (DCCI3) o 1.8 [m, 3 H, CH3], 2.3 [m, 2 H, H(3)], 4.3 [m, 2 H, H(2)], 6.8-7.5 
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[m, 4 H, Ar-H]; 13c NMR (DCCl3) ppm 27.7 [C(9)], 32.0 [C(4)], 34.4 [C(3)], 62.2 
[C(2)], 117.7[C(CN)]; Aromatic-C: 121.3, 121.4, 123.7, 127.7, 129.6, 153.2. 
4-Cyano-4-methyl-3,4-dihydro-2H -1-benzopyFan-6-methyl Ketone (104). 
A 100-mL, three-necked, round-bottomed flask was equipped with a magnetic stirrer, a 
condenser, and an addition funnel. To 0.9 g (5.2 mmol) of 4-cyano-4-methyl-3,4-
dihydro-2H-1-benzopyran (103) in 25 mL of CH3N02 was added a solution of 1.73 g 
(13 mmol) of anhydrous AlCl3 and 0.61 g (7.8 mmol) of CH3C(O)Cl in 10 mL. of 
CH3N02 over a period of 2 min. The color of the reaction mixture changed to dark 
reddish brown. This reaction mixture was stirred at room temperature for 24 h. It was 
then cooled in an ice bath for (15 min), and then 6 M HCl (10 mL) was added followed by 
10 mL of ether. The organic layer was separated and the aqueous layer was extracted with 
ether (3 x 15 mL). The combined organic layer was washed with water (2 x 15 mL), 
saturated NaHC03, and finally with brine (25 mL). The organic layer was dried 
(Na2S04), filtered and evaporated (rotary evaporator) to afford a dark brown-colored oil 
[1.1 g, 57%]. This oil solidified under vacuum (25"C/15 mm). IR (neat) 2200, 1660 
cm-1; lH NMR (DCCl3) B 1.82 [s, 3 H], 2.3 [m, 2 H], 2.5 [s, 3 H], 4.4 [m, 2 H], 6.9 [d, 
J = 8.63 Hz, 1 H], 7.83 [dd, J = 8.66 Hz, J = 2.14 Hz, 1 H], 8.06 [d, J = 2.17 Hz, 1 H]; 
13C NMR (DCC13) ppm 26.3 [C(l2)], 27.3 [C(9)], 32.1 [C(4)], 34.1 [C(3)], 62.8 [C(2)], 
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Concentration = 1.53 x 10·5 M 
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